CN104334134A - Absorbent article - Google Patents
Absorbent article Download PDFInfo
- Publication number
- CN104334134A CN104334134A CN201380028095.1A CN201380028095A CN104334134A CN 104334134 A CN104334134 A CN 104334134A CN 201380028095 A CN201380028095 A CN 201380028095A CN 104334134 A CN104334134 A CN 104334134A
- Authority
- CN
- China
- Prior art keywords
- chain hydrocarbon
- top layer
- acid
- fatty acid
- ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002250 absorbent Substances 0.000 title claims abstract description 88
- 230000002745 absorbent Effects 0.000 title claims abstract description 88
- 239000000203 mixture Substances 0.000 claims abstract description 36
- 239000000194 fatty acid Substances 0.000 claims description 196
- 210000004369 blood Anatomy 0.000 claims description 192
- 239000008280 blood Substances 0.000 claims description 192
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 186
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 185
- 229930195729 fatty acid Natural products 0.000 claims description 185
- 150000004665 fatty acids Chemical class 0.000 claims description 175
- 150000002430 hydrocarbons Chemical class 0.000 claims description 174
- 150000002148 esters Chemical class 0.000 claims description 151
- 229930195733 hydrocarbon Natural products 0.000 claims description 141
- 239000004215 Carbon black (E152) Substances 0.000 claims description 140
- -1 hydroxyls compound Chemical class 0.000 claims description 137
- 230000004048 modification Effects 0.000 claims description 125
- 238000012986 modification Methods 0.000 claims description 125
- 239000003795 chemical substances by application Substances 0.000 claims description 122
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 111
- 125000001931 aliphatic group Chemical group 0.000 claims description 106
- 150000001875 compounds Chemical class 0.000 claims description 81
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 78
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 75
- 239000000835 fiber Substances 0.000 claims description 68
- NOQGZXFMHARMLW-UHFFFAOYSA-N Daminozide Chemical group CN(C)NC(=O)CCC(O)=O NOQGZXFMHARMLW-UHFFFAOYSA-N 0.000 claims description 65
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 54
- 239000006096 absorbing agent Substances 0.000 claims description 50
- 239000004745 nonwoven fabric Substances 0.000 claims description 35
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 34
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 30
- 238000005452 bending Methods 0.000 claims description 27
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 24
- 239000007788 liquid Substances 0.000 claims description 24
- DJOWTWWHMWQATC-KYHIUUMWSA-N Karpoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1(O)C(C)(C)CC(O)CC1(C)O)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C DJOWTWWHMWQATC-KYHIUUMWSA-N 0.000 claims description 23
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 23
- 239000001301 oxygen Substances 0.000 claims description 23
- 229910052760 oxygen Inorganic materials 0.000 claims description 23
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 22
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 22
- 230000006835 compression Effects 0.000 claims description 22
- 238000007906 compression Methods 0.000 claims description 22
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims description 19
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 239000007789 gas Substances 0.000 claims description 13
- 150000001261 hydroxy acids Chemical class 0.000 claims description 13
- 150000004715 keto acids Chemical class 0.000 claims description 13
- 230000035699 permeability Effects 0.000 claims description 9
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 8
- 238000004049 embossing Methods 0.000 claims description 8
- 238000009940 knitting Methods 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 6
- 230000033228 biological regulation Effects 0.000 claims description 6
- 150000002576 ketones Chemical class 0.000 claims description 6
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 4
- 150000005215 alkyl ethers Chemical class 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 22
- 230000000149 penetrating effect Effects 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 199
- 229910052799 carbon Inorganic materials 0.000 description 87
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 82
- 210000002445 nipple Anatomy 0.000 description 73
- 235000011187 glycerol Nutrition 0.000 description 67
- 239000003921 oil Substances 0.000 description 61
- 235000019198 oils Nutrition 0.000 description 61
- 229940059574 pentaerithrityl Drugs 0.000 description 46
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 43
- 150000005690 diesters Chemical class 0.000 description 28
- 210000004914 menses Anatomy 0.000 description 20
- 150000001298 alcohols Chemical class 0.000 description 19
- 239000011248 coating agent Substances 0.000 description 19
- 238000000576 coating method Methods 0.000 description 19
- 238000000034 method Methods 0.000 description 19
- 238000007664 blowing Methods 0.000 description 16
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 16
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 15
- 150000002170 ethers Chemical class 0.000 description 15
- 229920001451 polypropylene glycol Polymers 0.000 description 15
- 210000000601 blood cell Anatomy 0.000 description 14
- 239000002131 composite material Substances 0.000 description 14
- 125000005456 glyceride group Chemical group 0.000 description 14
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 14
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 14
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 12
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 12
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 12
- 239000000463 material Substances 0.000 description 12
- 238000012546 transfer Methods 0.000 description 12
- 210000001124 body fluid Anatomy 0.000 description 11
- 239000010839 body fluid Substances 0.000 description 11
- 239000012188 paraffin wax Substances 0.000 description 11
- 229920000642 polymer Polymers 0.000 description 10
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 10
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 9
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 9
- 229920001519 homopolymer Polymers 0.000 description 9
- 239000000123 paper Substances 0.000 description 9
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 8
- 230000032050 esterification Effects 0.000 description 8
- 238000005886 esterification reaction Methods 0.000 description 8
- 230000002209 hydrophobic effect Effects 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 229920000247 superabsorbent polymer Polymers 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 230000003252 repetitive effect Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 229920002994 synthetic fiber Polymers 0.000 description 7
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical class OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 239000005022 packaging material Substances 0.000 description 6
- 239000004014 plasticizer Substances 0.000 description 6
- 238000012545 processing Methods 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- 150000003628 tricarboxylic acids Chemical class 0.000 description 6
- OBETXYAYXDNJHR-SSDOTTSWSA-M (2r)-2-ethylhexanoate Chemical compound CCCC[C@@H](CC)C([O-])=O OBETXYAYXDNJHR-SSDOTTSWSA-M 0.000 description 5
- 239000004698 Polyethylene Substances 0.000 description 5
- 239000004743 Polypropylene Substances 0.000 description 5
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 239000004744 fabric Substances 0.000 description 5
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000001000 micrograph Methods 0.000 description 5
- 229920000728 polyester Polymers 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- 229920000139 polyethylene terephthalate Polymers 0.000 description 5
- 239000005020 polyethylene terephthalate Substances 0.000 description 5
- 229920001155 polypropylene Polymers 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000004831 Hot glue Substances 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000011230 binding agent Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000010408 film Substances 0.000 description 4
- MNWFXJYAOYHMED-UHFFFAOYSA-N heptanoic acid Chemical compound CCCCCCC(O)=O MNWFXJYAOYHMED-UHFFFAOYSA-N 0.000 description 4
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 4
- 210000002381 plasma Anatomy 0.000 description 4
- 238000006068 polycondensation reaction Methods 0.000 description 4
- 230000006641 stabilisation Effects 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920002955 Art silk Polymers 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 3
- 241000282414 Homo sapiens Species 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 150000001721 carbon Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- ZQPPMHVWECSIRJ-MDZDMXLPSA-N elaidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCC(O)=O ZQPPMHVWECSIRJ-MDZDMXLPSA-N 0.000 description 3
- 235000019197 fats Nutrition 0.000 description 3
- 238000005227 gel permeation chromatography Methods 0.000 description 3
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 239000011256 inorganic filler Substances 0.000 description 3
- 229910003475 inorganic filler Inorganic materials 0.000 description 3
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000002885 octadecanoids Chemical class 0.000 description 3
- 239000008601 oleoresin Substances 0.000 description 3
- 238000004806 packaging method and process Methods 0.000 description 3
- UWJJYHHHVWZFEP-UHFFFAOYSA-N pentane-1,1-diol Chemical compound CCCCC(O)O UWJJYHHHVWZFEP-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000005871 repellent Substances 0.000 description 3
- 230000002940 repellent Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 239000004575 stone Substances 0.000 description 3
- 229920006132 styrene block copolymer Polymers 0.000 description 3
- 229920001169 thermoplastic Polymers 0.000 description 3
- 239000004416 thermosoftening plastic Substances 0.000 description 3
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 2
- UNSRRHDPHVZAHH-YOILPLPUSA-N (5Z,8Z,11Z)-icosatrienoic acid Chemical compound CCCCCCCC\C=C/C\C=C/C\C=C/CCCC(O)=O UNSRRHDPHVZAHH-YOILPLPUSA-N 0.000 description 2
- HXQHFNIKBKZGRP-URPRIDOGSA-N (5Z,9Z,12Z)-octadecatrienoic acid Chemical compound CCCCC\C=C/C\C=C/CC\C=C/CCCC(O)=O HXQHFNIKBKZGRP-URPRIDOGSA-N 0.000 description 2
- YWWVWXASSLXJHU-AATRIKPKSA-N (9E)-tetradecenoic acid Chemical compound CCCC\C=C\CCCCCCCC(O)=O YWWVWXASSLXJHU-AATRIKPKSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- KMZHZAAOEWVPSE-UHFFFAOYSA-N 2,3-dihydroxypropyl acetate Chemical compound CC(=O)OCC(O)CO KMZHZAAOEWVPSE-UHFFFAOYSA-N 0.000 description 2
- UNSRRHDPHVZAHH-UHFFFAOYSA-N 6beta,11alpha-Dihydroxy-3alpha,5alpha-cyclopregnan-20-on Natural products CCCCCCCCC=CCC=CCC=CCCCC(O)=O UNSRRHDPHVZAHH-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920003043 Cellulose fiber Polymers 0.000 description 2
- 239000004347 Glyceryl monoacetate Substances 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 206010021639 Incontinence Diseases 0.000 description 2
- VQTUBCCKSQIDNK-UHFFFAOYSA-N Isobutene Chemical compound CC(C)=C VQTUBCCKSQIDNK-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- HXQHFNIKBKZGRP-UHFFFAOYSA-N Ranuncelin-saeure-methylester Natural products CCCCCC=CCC=CCCC=CCCCC(O)=O HXQHFNIKBKZGRP-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 150000001345 alkine derivatives Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 238000000635 electron micrograph Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N glutaric acid Chemical compound OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 235000019442 glyceryl monoacetate Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- ZWRUINPWMLAQRD-UHFFFAOYSA-N nonan-1-ol Chemical compound CCCCCCCCCO ZWRUINPWMLAQRD-UHFFFAOYSA-N 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- IJTNSXPMYKJZPR-UHFFFAOYSA-N parinaric acid Chemical compound CCC=CC=CC=CC=CCCCCCCCC(O)=O IJTNSXPMYKJZPR-UHFFFAOYSA-N 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920005604 random copolymer Polymers 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- CXMXRPHRNRROMY-UHFFFAOYSA-N sebacic acid Chemical compound OC(=O)CCCCCCCCC(O)=O CXMXRPHRNRROMY-UHFFFAOYSA-N 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 description 2
- 230000001629 suppression Effects 0.000 description 2
- 239000012209 synthetic fiber Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- VHOCUJPBKOZGJD-UHFFFAOYSA-N triacontanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O VHOCUJPBKOZGJD-UHFFFAOYSA-N 0.000 description 2
- KQTIIICEAUMSDG-UHFFFAOYSA-N tricarballylic acid Chemical compound OC(=O)CC(C(O)=O)CC(O)=O KQTIIICEAUMSDG-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- BITHHVVYSMSWAG-KTKRTIGZSA-N (11Z)-icos-11-enoic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCC(O)=O BITHHVVYSMSWAG-KTKRTIGZSA-N 0.000 description 1
- XSXIVVZCUAHUJO-AVQMFFATSA-N (11e,14e)-icosa-11,14-dienoic acid Chemical compound CCCCC\C=C\C\C=C\CCCCCCCCCC(O)=O XSXIVVZCUAHUJO-AVQMFFATSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N 1-Butene Chemical compound CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 1
- YIWUKEYIRIRTPP-UHFFFAOYSA-N 2-ethylhexan-1-ol Chemical compound CCCCC(CC)CO YIWUKEYIRIRTPP-UHFFFAOYSA-N 0.000 description 1
- JBGDSVVIBTXYJD-UHFFFAOYSA-N 2-hydroxy-4-oxopentane-1,2,3-tricarboxylic acid Chemical compound CC(=O)C(C(O)=O)C(O)(C(O)=O)CC(O)=O JBGDSVVIBTXYJD-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 1
- KBIWNQVZKHSHTI-UHFFFAOYSA-N 4-n,4-n-dimethylbenzene-1,4-diamine;oxalic acid Chemical compound OC(=O)C(O)=O.CN(C)C1=CC=C(N)C=C1 KBIWNQVZKHSHTI-UHFFFAOYSA-N 0.000 description 1
- YWWVWXASSLXJHU-UHFFFAOYSA-N 9E-tetradecenoic acid Natural products CCCCC=CCCCCCCCC(O)=O YWWVWXASSLXJHU-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- QQXWWCIEPUFZQL-YAJBEHDUSA-N Bosseopentaenoic acid Natural products CCCCCC=C/C=C/C=C/C=CCC=C/CCCC(=O)O QQXWWCIEPUFZQL-YAJBEHDUSA-N 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000009261 D 400 Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
- XTJFFFGAUHQWII-UHFFFAOYSA-N Dibutyl adipate Chemical compound CCCCOC(=O)CCCCC(=O)OCCCC XTJFFFGAUHQWII-UHFFFAOYSA-N 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 235000021297 Eicosadienoic acid Nutrition 0.000 description 1
- 235000009967 Erodium cicutarium Nutrition 0.000 description 1
- 240000003759 Erodium cicutarium Species 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Chemical class OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- OPGOLNDOMSBSCW-CLNHMMGSSA-N Fursultiamine hydrochloride Chemical compound Cl.C1CCOC1CSSC(\CCO)=C(/C)N(C=O)CC1=CN=C(C)N=C1N OPGOLNDOMSBSCW-CLNHMMGSSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 241000047703 Nonion Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 229920000305 Nylon 6,10 Polymers 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Natural products OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 235000021322 Vaccenic acid Nutrition 0.000 description 1
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 1
- 239000003377 acid catalyst Substances 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000001351 alkyl iodides Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- AHANXAKGNAKFSK-PDBXOOCHSA-N all-cis-icosa-11,14,17-trienoic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCCC(O)=O AHANXAKGNAKFSK-PDBXOOCHSA-N 0.000 description 1
- CUXYLFPMQMFGPL-FWSDQLJQSA-N alpha-Eleostearic acid Natural products CCCCC=CC=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-FWSDQLJQSA-N 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- IJTNSXPMYKJZPR-WVRBZULHSA-N alpha-parinaric acid Natural products CCC=C/C=C/C=C/C=CCCCCCCCC(=O)O IJTNSXPMYKJZPR-WVRBZULHSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- QQXWWCIEPUFZQL-JMFSJNRSSA-N bosseopentaenoic acid Chemical compound CCCCC\C=C/C=C/C=C/C=C\C\C=C/CCCC(O)=O QQXWWCIEPUFZQL-JMFSJNRSSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- ZPFKRQXYKULZKP-UHFFFAOYSA-N butylidene Chemical group [CH2+]CC[CH-] ZPFKRQXYKULZKP-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000000113 differential scanning calorimetry Methods 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- IXLCRBHDOFCYRY-UHFFFAOYSA-N dioxido(dioxo)chromium;mercury(2+) Chemical compound [Hg+2].[O-][Cr]([O-])(=O)=O IXLCRBHDOFCYRY-UHFFFAOYSA-N 0.000 description 1
- KPUWHANPEXNPJT-UHFFFAOYSA-N disiloxane Chemical class [SiH3]O[SiH3] KPUWHANPEXNPJT-UHFFFAOYSA-N 0.000 description 1
- KQTXIZHBFFWWFW-UHFFFAOYSA-L disilver;carbonate Chemical compound [Ag]OC(=O)O[Ag] KQTXIZHBFFWWFW-UHFFFAOYSA-L 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- BYNVYIUJKRRNNC-UHFFFAOYSA-N docosanoic acid;propane-1,2,3-triol Chemical compound OCC(O)CO.CCCCCCCCCCCCCCCCCCCCCC(O)=O BYNVYIUJKRRNNC-UHFFFAOYSA-N 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- IQLUYYHUNSSHIY-HZUMYPAESA-N eicosatetraenoic acid Chemical compound CCCCCCCCCCC\C=C\C=C\C=C\C=C\C(O)=O IQLUYYHUNSSHIY-HZUMYPAESA-N 0.000 description 1
- PRHHYVQTPBEDFE-UHFFFAOYSA-N eicosatrienoic acid Natural products CCCCCC=CCC=CCCCCC=CCCCC(O)=O PRHHYVQTPBEDFE-UHFFFAOYSA-N 0.000 description 1
- 229940108623 eicosenoic acid Drugs 0.000 description 1
- BITHHVVYSMSWAG-UHFFFAOYSA-N eicosenoic acid Natural products CCCCCCCCC=CCCCCCCCCCC(O)=O BITHHVVYSMSWAG-UHFFFAOYSA-N 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 210000003617 erythrocyte membrane Anatomy 0.000 description 1
- 125000005677 ethinylene group Chemical group [*:2]C#C[*:1] 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- GHUOUGGZZJXPRM-UHFFFAOYSA-N ethyl 2-amino-5-(4-chlorophenyl)-1,3-thiazole-4-carboxylate Chemical compound N1=C(N)SC(C=2C=CC(Cl)=CC=2)=C1C(=O)OCC GHUOUGGZZJXPRM-UHFFFAOYSA-N 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000004508 fractional distillation Methods 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-QXMHVHEDSA-N gadoleic acid Chemical compound CCCCCCCCCC\C=C/CCCCCCCC(O)=O LQJBNNIYVWPHFW-QXMHVHEDSA-N 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- AEYWGSNMPNEILM-UHFFFAOYSA-N heptane-1,1,1-tricarboxylic acid Chemical class CCCCCCC(C(O)=O)(C(O)=O)C(O)=O AEYWGSNMPNEILM-UHFFFAOYSA-N 0.000 description 1
- XMHIUKTWLZUKEX-UHFFFAOYSA-N hexacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCC(O)=O XMHIUKTWLZUKEX-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-IHWYPQMZSA-N isocrotonic acid Chemical compound C\C=C/C(O)=O LDHQCZJRKDOVOX-IHWYPQMZSA-N 0.000 description 1
- 239000012948 isocyanate Substances 0.000 description 1
- 150000002513 isocyanates Chemical class 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229920001684 low density polyethylene Polymers 0.000 description 1
- 239000004702 low-density polyethylene Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000004531 microgranule Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 1
- WSGCRAOTEDLMFQ-UHFFFAOYSA-N nonan-5-one Chemical compound CCCCC(=O)CCCC WSGCRAOTEDLMFQ-UHFFFAOYSA-N 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- WLJVNTCWHIRURA-UHFFFAOYSA-N pimelic acid Chemical compound OC(=O)CCCCCC(O)=O WLJVNTCWHIRURA-UHFFFAOYSA-N 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 150000003097 polyterpenes Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229920006298 saran Polymers 0.000 description 1
- 150000003333 secondary alcohols Chemical class 0.000 description 1
- 230000011218 segmentation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- JIWBIWFOSCKQMA-UHFFFAOYSA-N stearidonic acid Natural products CCC=CCC=CCC=CCC=CCCCCC(O)=O JIWBIWFOSCKQMA-UHFFFAOYSA-N 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- UAXOELSVPTZZQG-UHFFFAOYSA-N tiglic acid Natural products CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 1
- ILJSQTXMGCGYMG-UHFFFAOYSA-N triacetic acid Chemical compound CC(=O)CC(=O)CC(O)=O ILJSQTXMGCGYMG-UHFFFAOYSA-N 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 238000009941 weaving Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers of the pads
- A61F13/511—Topsheet, i.e. the permeable cover or layer facing the skin
- A61F13/51104—Topsheet, i.e. the permeable cover or layer facing the skin the top sheet having a three-dimensional cross-section, e.g. corrugations, embossments, recesses or projections
- A61F13/51108—Topsheet, i.e. the permeable cover or layer facing the skin the top sheet having a three-dimensional cross-section, e.g. corrugations, embossments, recesses or projections the top sheet having corrugations or embossments having one axis relatively longer than the other axis, e.g. forming channels or grooves in a longitudinal direction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers of the pads
- A61F13/511—Topsheet, i.e. the permeable cover or layer facing the skin
- A61F13/51113—Topsheet, i.e. the permeable cover or layer facing the skin comprising an additive, e.g. lotion or odour control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Materials For Medical Uses (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Provided is an absorbent article (1) that is capable of preventing detachment of a sheet that constitutes a wing section (6), said detachment resulting from a composition that is applied to a top sheet (2) penetrating the wing section (6) when said wing section (6) has been folded and bent. A protruding section (21) is provided to the top sheet (2) of the absorbent article (1) of the present invention in an excretory orifice contact region (16) that is at least in contact with the excretory orifice of a wearer on the skin-side surface of said contact region. The top sheet (2) is additionally provided with a composition application region (18) to which a predetermined composition is applied at least in the region (16) that is in contact with the excretory orifice of the wearer.
Description
Technical field
The present invention relates to the absorbent commodities such as sanitary napkin, sanitary pad, incontinence towel, incontinence protection.
Background technology
The absorbent commodity of skin care compositions is given as prior art known (such as patent documentation 1) to the top layer of main part.The top layer of this absorbent commodity uses the form film of perforate.In addition, the wing formed in width prolongation on top layer is provided with at this absorbent commodity.
Prior art document
Patent documentation
Patent documentation 1: Japanese Unexamined Patent Application Publication 2003-510164 publication
Summary of the invention
the problem that invention will solve
In order to the absorbent commodity package cargo will recorded in patent documentation 1 during bending alar part, the perforate part on the top layer in the alar part of the skin care compositions that the top layer of main part is given likely by bending and be infiltrated up to alar part.Now, the top layer due to infiltrated skin care compositions in alar part and the joint between bottom die down, and during long-time use absorbent commodity, top layer is likely peeled off by bottom.
The object of the invention is to, provide the compositions owing to coating top layer during bending alar part to be infiltrated up to alar part and the sheet material that forms alar part is peeled off and obtained the absorbent commodity of suppression.
for the scheme of dealing with problems
The present invention adopts following technical scheme in order to solve the problem.
Namely, the present invention is a kind of absorbent commodity, it has length direction and width, a pair alar part that the both side edges comprising main part and main body is extended at width, main part possesses the top layer of the non-woven fabrics of the liquid permeability being arranged at skin side, be arranged at the liquid-impermeable bottom of the garment side of dress and be arranged at the absorber of the liquid retainability between top layer and bottom, the at least scavenge port contact area of top layer in the face of skin side possesses teat, described scavenge port contact area contacts with the scavenge port of wearer, top layer at least also possesses the compositions dispensing area being coated with regulation compositions at scavenge port contact area.
Another the present invention is a kind of absorbent commodity, it has length direction and width, a pair alar part that the both side edges comprising main part and main body is extended at width, main part possesses the top layer of the non-woven fabrics of the liquid permeability being arranged at skin side, be arranged at the liquid-impermeable bottom of the garment side of dress and be arranged at the absorber of the liquid retainability between top layer and bottom, at least scavenge port contact area in the face of skin side possesses the inside being arrived absorber by top layer, processed by embossing and the compression unit formed, described scavenge port contact area contacts with the scavenge port of wearer, top layer at least possesses the compositions dispensing area being coated with regulation compositions at scavenge port contact area.
the effect of invention
According to the present invention, the compositions owing to coating top layer during bending alar part can be suppressed to be infiltrated up to alar part and form alar part sheet material peel off.
Accompanying drawing explanation
Fig. 1 is the portion fractures top view of an embodiment of absorbent commodity of the present invention.
Fig. 2 is the schematic cross-section in the A-A line cross section representing Fig. 1.
Fig. 3 is the figure of teat for illustration of the top layer in the absorbent commodity of one embodiment of the present invention and recess.
Fig. 4 is the figure for illustration of the method forming teat and recess on top layer.
Fig. 5 is the figure for illustration of the absorbent commodity of the one embodiment of the present invention of bending alar part in order to pack.
Fig. 6 is the axonometric chart of the package of the absorbent commodity comprising one embodiment of the present invention.
Fig. 7 is the schematic cross-section in the D-D line cross section representing Fig. 5.
Fig. 8 is the figure for illustration of the teat on the top layer in the variation of the absorbent commodity of one embodiment of the present invention, recess and peristome.
Fig. 9 is the figure of method of the peristome for illustration of the absorbent commodity variation forming one embodiment of the present invention.
Figure 10 is the figure of the teat for illustration of the top layer in the variation of the absorbent commodity of one embodiment of the present invention.
Figure 11 is the figure for illustration of the teat on the top layer in the variation of the absorbent commodity of one embodiment of the present invention, recess and peristome.
Figure 12 is the figure of the variation of absorbent commodity for illustration of one embodiment of the present invention.
Figure 13 is the figure of the variation of absorbent commodity for illustration of one embodiment of the present invention.
Figure 14 is the electron micrograph that the skin contact face on the top layer in the sanitary napkin of three C2L fatty acid oil glyceride is contained on top layer.
Figure 15 is the microphotograph of the menses containing or do not contain blood modification agent.
Figure 16 is the figure for illustration of capillary assay method.
Detailed description of the invention
Referring to accompanying drawing, the present invention will be described, but the present invention not by accompanying drawing record limit.
Fig. 1 is the portion fractures top view of the absorbent commodity of one embodiment of the present invention, and Fig. 2 is the schematic cross-section in the A-A line cross section representing Fig. 1.Absorbent commodity 1 comprises: the top layer 2 possessing the liquid permeability being arranged at skin side (skin contact side), be arranged at dress garment side (non-skin contact side) liquid-impermeable bottom 3, be arranged at the absorber 4 of the liquid retainability between top layer 2 and bottom 3 and be arranged at the main part 10 of liquid-impermeable sidepiece sheet 5 of width both sides on top layer 2; Extend, possess a pair alar part 6 of sidepiece sheet 5 and bottom 3 at width with the both side edges of main body 10.
Reference numeral 61 represents the root (boundary between main part 10 and alar part 6) of alar part 6.Such as in the length direction both sides of alar part 6, the straight line that two points that the width of absorbent commodity 1 increases suddenly are formed by connecting can regard the root 61 of alar part 6 as.The face of the garment side of the dress of alar part 6 is provided with bonding part 7.In addition, bonding part 7 is also provided with in the face of the garment side of the dress of main part 10.It should be noted that, in Fig. 1, the width of absorbent commodity 1 is X-direction, length direction is Y-direction.In addition, the in-plane of absorbent commodity 1 is XY direction.It should be noted that also sidepiece sheet 5 can not be set, and the top layer 2 of main part 10 is extended at width, thus alar part 6 possesses top layer 2 and bottom 3.
If the shape that the shape rectangle, ellipse, hourglass shape etc. of main part 10 are suitable for the health of women and the shape of underwear is not particularly limited.The total of the length direction in the profile of main part 10 is preferably dimensioned to be 100 ~ 500mm, is more preferably 150 ~ 350mm.In addition, the total of the width in the profile of main part 10 is preferably dimensioned to be 30 ~ 200mm, is more preferably 40 ~ 180mm.
Top layer 2 makes the body fluid such as urine, menses of being discharged by wearer move to absorber 4.All or part of of top layer 2 has liquid permeability, the transparent liquid region on top layer 2 can by the non-woven fabrics of liquid permeability, the resin film of many liquid drain hole of weaving cotton cloth, be formed or the mesh sheets etc. with many meshes formed.
Top layer 2 is preferably made by non-woven fabrics.As the raw material of non-woven fabrics that top layer 2 uses, can use in natural fiber, chemical fibre any one.As the example of natural fiber, can list and pulverize the cellulose such as pulp, Cotton Gossypii.As the example of chemical fibre, semisynthetic fibre element, thermoplastic hydrophobic's chemical fibres such as the regenerated cellulose such as artificial silk and fibrillation artificial silk, acetas and triacetate can be listed and implement thermoplastic hydrophobic's chemical fibre of hydrophilicity-imparting treatment.As thermoplastic hydrophobic's chemical fibre, the ultimate fibres such as polyethylene (PE), polypropylene (PP), polyethylene terephthalate (PET) can be listed, the composite fibres such as the fiber of PE and PP glycerol polymerization and core sheath structure.
When making the non-woven fabrics used in top layer 2, any one or composite dry method in dry process (combing method, spun-bond process, meltblown, air laid etc.) and damp process and damp process can be implemented to be implemented as net.As the adhesive bonding method of the net during non-woven fabrics used in making top layer 2, the methods such as heat bonding, acupuncture, chemical adhesion can be listed, but be not limited to these methods.In addition, also top layer 2 can be used for utilizing current intertexture method with the spun laced fabric that sheet is formed.
The fiber of non-woven fabrics used in top layer 2, can use the fusing point of core composition higher than the composite fibre of the different parallel-type of the fusing point of the core sheath type of sheath composition, the core shift type of core sheath or left and right composition.In addition, can by the fiber of hollow type, flat, the heterotypic fibre such as Y type and C type, latent crimp or show at curling stereo crimped fiber, the non-woven fabrics that the fiber mixing such as the segmentation fiber be split to form by the load physically such as current, heat or embossing processing are used in top layer 2.
If consider the entering of liquid, sensation when contacting skin, then the fiber number of the fiber of the non-woven fabrics used in top layer 2 is preferably 1.1 ~ 8.8dtex (dtex).
When top layer 2 uses hydrophobic synthetic fibre, the entering of the liquid on top layer 2 can be considered, bleed back, hydrophilizing agent, water repellent etc. are mixed into hydrophobic synthetic fibre or with the coating such as hydrophilizing agent, water repellent hydrophobic synthetic fibre.In addition, can sided corona treatment, Cement Composite Treated by Plasma be passed through, give hydrophilic to hydrophobic synthetic fibre.Thus, blood modification agent described later is in oil loving situation, sparsely to coexist hydrophilic portion and oleophilic portion at blood modification agent dispensing area 18, the hydrophilic composition (mainly blood plasma) of body fluid (such as menses) and lipophilic ingredients (mainly blood cell) both promptly move to absorber 4 by top layer 2.
In order to improve the disguise on top layer 2, in the fiber of the non-woven fabrics used in top layer 2, the inorganic fillers such as titanium oxide, barium sulfate and calcium carbonate can be contained.When the fiber of non-woven fabrics is the composite fibre of core sheath type, can only contains inorganic filler, also only can contain inorganic filler by sheath by core.
The blood modification agent dispensing area 18 being coated with blood modification agent described later is provided with at least scavenge port contact area 16 on top layer 2.At this, scavenge port contact area 16 refers to length preferably 50 ~ 200mm, the more preferably 70 ~ 150mm of the length direction centered by the position that the scavenge port of the body fluid with wearer contacts, length preferably 10 ~ 80mm, the more preferably 20 ~ 50mm of width.In order to absorbent commodity 1 is packed, if the mode contacted with each other with the edge 62 outside the width of a pair alar part 6 is by inside the bending to width of a pair alar part 6, then blood modification agent dispensing area 18 major part or all the alar part 6 of part by bending to cover (with reference to Fig. 5 and Fig. 7).
Top layer 2 at least have at scavenge port contact area 16 extend at length direction (Y-direction), the teat 21 that arranges at the direction such as width (X-direction) intersected with length direction (Y-direction) and recess 22.With reference to Fig. 3, the teat 21 and recess 22 that are arranged at top layer 2 are described in detail.Fig. 3 is the axonometric chart teat 21 on top layer 2 and recess 22 amplified.It should be noted that, if the direction that the direction that teat 21 and recess 22 extend specifies then is not limited to length direction.
As shown in Figure 3, top layer 2 be included in that length direction (Y-direction) extends, multiple teats 21 of arranging at the direction such as width (X-direction) intersected with length direction (Y-direction) and recess 22.The shape in the cross section of teat 21 is such as roughly U-shaped.Roughly U-shaped is except U-shaped, also comprises the additional shape rounding angle or changed into by straight line formation U-shaped when curve etc. is out of shape.Such as roughly U-shaped also comprises V-shape, M word shape and trapezoidal.In addition, the cross sectional shape of teat 21 can form Ω shape.
The thickness of the thickest part of teat 21 is preferably 0.3 ~ 15mm, is more preferably 0.5 ~ 5mm.In addition, the length of the width (X-direction) of teat is preferably 0.5 ~ 30mm, is more preferably 1.0 ~ 10mm.Distance (spacing) between the summit of the width (X-direction) of adjacent teat is preferably 0.5 ~ 30mm, is more preferably 3 ~ 10mm.The thickness of the thinnest part of recess 22, is preferably 1 ~ 50% relative to the thickness of the thickest part of teat 21, is more preferably 5 ~ 20%.The length of the width (X-direction) of recess 22 is preferably 0.1 ~ 30mm, is more preferably 0.5 ~ 10mm.
The fibre density of the central part 23 of teat 21 preferably than the sidepiece 24 of teat 21 and/or the fibre density of recess 22 low.The central part 23 of such as teat 21 and the fibre density of recess 22 are 0.005 ~ 0.20g/cm
3, be preferably 0.007 ~ 0.07g/cm
3.The fibre density at each position on top layer such as can measure as follows.The top layer of length of operating direction (MD) of the regulation being formed with teat 21 and recess 22 is sampled.Then, use the microphotograph in the cross section of the width (CD) on the shooting top layers such as microscope, use the sectional area of central part of the teat 21 in image processing apparatus mensuration top layer, the sectional area of the sidepiece of teat and the sectional area of recess.Then use the cooling top layers such as liquid nitrogen, cut the central part of the teat on chilled top layer, the sidepiece of teat and recess from top layer respectively.Then, the weight of the central part of teat, the sidepiece of teat and the recess that cut is measured respectively.Finally, the each weight recorded of the central part of teat, the sidepiece of teat and recess, divided by above-mentioned operating direction (MD) length and sectional area, can calculate the fibre density of the central part of the teat on top layer, the fibre density of the sidepiece of teat and the fibre density of recess thus.In addition, the magnitude relationship between the fibre density of the fibre density of the central part 23 of teat 21 and the sidepiece 24 of teat 21 and/or recess 22, can be judged by the density relation of the fiber of the cross sectional microscopy photo on top layer.The Reference numeral 25 of fibre density represents the fiber on top layer 2.
Then with reference to Fig. 4, the method forming teat 21 and recess 22 on top layer 2 is described.As shown in Figure 4, the sheet 120 of knitting becoming the material on top layer 2 is configured on netted supporting member 130, then mobile at operating direction (MD).Knit sheet 120 to move between blowing unit 140 and suction unit 150.Gas 141 is ejected into and knits sheet 120 by blowing unit 140, and suction unit 150 attracts the gas 141 sprayed by blowing unit 140.The gas 141 sprayed by blowing unit 140 pushes the fiber knitting sheet 120 aside.Thus, be formed at corresponding to the chase 122 of the recess 22 on top layer 2 and knit sheet 120.In addition, the fibril aggregation pushed aside by the gas 141 sprayed by blowing unit 140 is in the both sides of chase 122.Thus, the both sides of chase 122 are formed at corresponding to the teat 121 of the teat 21 on top layer 2.
Netted supporting member 130 is for having the netted supporting mass of breathability.Such as can use and knit spiral by plain weave twill weave crowfoot satin bilayer and to knit etc. and inweave the peucinous silks such as polyester, polyphenylene sulfide, nylon, conductive monofilaments, or the breathability net of the metallic silk such as rustless steel, copper, aluminum etc. is as netted supporting member 130.
Multiple ejiction openings (not shown) of width arrangement are included in blowing unit 140.Thus, the multi beam gas 141 arranged at width (CD) can be ejected into and knit sheet 120 by blowing unit 140.In addition, the gas 141 sprayed by blowing unit 140 is such as room temperature or nitrogen, air and steam through heating.The gas 141 sprayed by blowing unit 140 can contain the microgranule of liquid or solid.
By making blowing unit 140 move back and forth at width (CD), the chase portion of the shape that crawls (wavy, zigzag fashion) can be formed at and knit sheet.In addition, knitting sheet 120 by being intermittently ejected into by gas 141 by blowing unit 140, discontinuous chase can be formed at and knit sheet.
The side of teat 121 is due to pushed aside fiber compression, and therefore the fibre density of the side of teat 121 raises.In addition, chase 122, owing to spraying the gas 141 sprayed by blowing unit 140, is knitted sheet and is compressed, and the fibre density therefore in chase 122 raises.On the other hand, in the central part of teat 121, although the fibril aggregation pushed aside, do not compressed by the gas 141 sprayed by blowing unit 140, therefore the fibre density of the central part of teat 121 reduces.Thus, the fibre density of the central part 23 of teat 21, reduction compared with the sidepiece 24 of teat 21 and/or the fibre density of recess 22.
Bottom 3 shown in Fig. 1 and Fig. 2 prevents the body fluid by absorber 4 absorbs from escaping to outside.Bottom 3 uses not through the material of body fluid.Such as bottom 3, use the plastic sheeting of impermeability or the laminates etc. of non-woven fabrics and impermeability plastic sheeting such as hydrophobic non-woven fabrics, polyethylene and polypropylene.In addition, spunbond melt-spun spunbond (SMS) fabric nonwoven cloth that the spun-bonded non-woven fabrics that the melt spraying non-woven fabrics intensity that resistance to water can be used high is strong clips is as bottom 3.By use not by the material with breathability of body fluid as bottom 3, sultry when can reduce wearing.Bottom 3 uses the bonding agents such as hot-melt adhesive to engage with top layer 2.
Absorber 4 absorbs and keeps body fluid.Absorber 4 preferably bulk, not easily lose shape, chemically stimulate little absorber.Such as, as absorber 4, use the composite absorber formed by fine hair shape pulp or air-laid nonwoven fabrics and superabsorbent polymer (SAP).This composite absorber can be covered by the material of the liquid permeabilities such as thin paper.
In addition, substitute the fine hair shape pulp of above-mentioned composite absorber, such as, can use the artificial fiber cellulose fibers such as chemipulp, cellulose fibre, artificial silk and acetas.The basic weight of the absorbency fibers such as the pulp in above-mentioned composite absorber is preferably 100g/m
2above and 800g/m
2below, the mass ratio of the superabsorbent polymer in above-mentioned composite absorber, using absorbency fiber as 100% time be preferably more than 10% and less than 65%.The basic weight covering the material of the liquid permeabilities such as the thin paper of above-mentioned compound mixture is preferably 12g/m
2above and 30g/m
2below.
As the air-laid nonwoven fabrics of above-mentioned compound mixture, such as, can use the non-woven fabrics of pulp and synthetic fibers thermal welding or pulp and synthetic fibers binding agent non-woven fabrics fixedly.
The superabsorbent polymer of above-mentioned composite absorber has the suitably crosslinked three-dimensional mesh structure of water soluble polymer.This absorbable polymer is relative to the water of the volume-absorption 30 ~ 60 times of the absorbable polymer absorbed before water.But this absorbable polymer is water-insoluble in essence.In addition, though this absorbable polymer apply great pressure, also can not will temporarily absorb water dehydration.As this absorbable polymer, such as, use starch-series, the graininess of acrylic acid series or aminoacid system or fibrous polymer.
The shape of absorber 4 and structure can change as required, and the integral dose of absorber 4 needs to correspond to the design insertion as absorbent commodity 1 and desired purposes.In addition, the size, absorbability etc. of absorber 4 change according to purposes.
Use hot-melt adhesive that absorber 4 is bonding with top layer 2.Top layer 2 can be suppressed thus to be peeled off by absorber 4.
Sidepiece sheet 5 prevents body fluid from being escaped to by the surface on top layer 2 and/or inside outside the width of absorbent commodity 1.Sidepiece sheet 5 preferably has hydrophobicity or water repellency.Sidepiece sheet 5 such as uses spun-bonded non-woven fabrics, SMS non-woven fabrics etc.In addition, due to sidepiece sheet 5 and the skin contact of wearer, preferably can reduce and sidepiece sheet 5 will be used for the Breathable nonwoven of the friction of skin.It should be noted that, absorbent commodity 1 can not have sidepiece sheet 5.
As mentioned above, alar part 6 is arranged at absorbent commodity 1 in order to absorbent commodity 1 is stably fixed on underwear.By the outer surface rear flank of alar part 6 bending to underwear, be pasted on the crotch of underwear via bonding part 7, absorbent commodity 1 stably can be fixed on underwear thus.In addition, by the bonding part 7 being arranged at main part 10 being pasted on the crotch of underwear, main part 10 in wearing can be suppressed to move.
The bonding part 7 of the absorbent commodity 1 shown in Fig. 2, is fixed on the crotch of underwear by absorbent commodity 1.As forming the binding agent of bonding part 7, such as use in styrenic, viscosifier, plasticizer suitably any one be the binding agent of main component.As aforementioned styrenic, styrene-ethylene-butylene-styrene block copolymer, styrene-butylene polymer, styrene-butylene-styrene block copolymer, styreneisobutylene-styrol copolymer etc. can be listed, can only use among them a kind of, also can be two or more blend polymer.Wherein, from the viewpoint of good thermal stability, be preferably styrene-ethylene-butylene-styrene block copolymer.
In addition, as foregoing tackifiers and plasticizer, be viscosifier and the plasticizer of solid under preferably can using room temperature, for viscosifier, such as C5 through-stone oleoresin, C9 through-stone oleoresin, dicyclopentadiene through-stone oleoresin, rosin series Petropols, polyterpene resin, terpene phenol resin etc. can be listed, for aforementioned plasticizer, such as except the monomeric plasticizers such as tricresyl phosphate, dibutyl phthalate, dioctyl phthalate, also can list the polymeric plasticizer such as polyvinyl, polyester.
As depicted in figs. 1 and 2, top layer 2 and absorber 4 have by embossing processing compress at thickness direction the compression chase 8 being arrived absorber 4 inside by top layer 2 formed.Compression chase 8 suppresses the diffusion of body fluids being discharged to the core (part contacted with the body fluid scavenge port of wearer) of absorbent commodity 1 to width (X-direction).In addition, top layer 2 can be suppressed thus to be peeled off by absorber 4.Compression chase 8 surrounds the core of absorbent commodity 1, has the shape of successional roughly ring-type.It should be noted that, the compression chase 8 surrounding the central part of absorbent commodity 1 can partly be interrupted.That is, the shape that chase 8 can have the roughly ring-type of noncontinuity is compressed.
In addition, by heat embossing processing by top layer 2 and bottom 3 compression engagement, form sealing 9 in the part of the part of the length direction both sides of the edge of main part 10 and the width outer ledge of alar part 6 thus.Thus, top layer 2 can be made can not to be peeled off by bottom 3.And then, by heat embossing processing, bottom 3 is engaged with the sealing 9 of sidepiece sheet 5 at alar part 6.Thus, sidepiece sheet 5 can be made can not to be peeled off by bottom 3.
Then above-mentioned blood modification agent is described in detail.Blood modification agent has the water solubility that the IOB of about 0.00 ~ about 0.60, the fusing point of less than about 45 DEG C and the water 100g relative to 25 DEG C are about 0.00 ~ about 0.05g.
IOB (inorganic organic balanced, Inorganic Organic Balance) is the index representing hydrophilic and oil loving balance, in this description, refers to the value calculated by the following formula of people's propositions such as little field.
IOB=inorganic value/organic value
Above-mentioned inorganic value and organic value " have Machine compound to give Measuring と and have Machine concept figure " (prediction of organic compound and organic conceptional diagram) to change Collar territory (Japanese The Chemicals) Vol.11, No.10 (1957) p.719-725 based on Tentianmu) the middle organic conceptional diagram recorded.The organic value of the essential groups that rattan Tian Shi proposes and inorganic value are summarized in following table 1.
Table 1
| Group | Inorganic value | Organic value |
| -COOH | 150 | 0 |
| -OH | 100 | 0 |
| -O-CO-O- | 80 | 0 |
| -CO- | 65 | 0 |
| -COOR | 60 | 0 |
| -O- | 20 | 0 |
| Triple bond | 3 | 0 |
| Double bond | 2 | 0 |
| CH 2 | 0 | 20 |
| Different branching | 0 | -10 |
| Tertiary branching | 0 | -20 |
| Light metal (salt) | ≥500 | 0 |
| Heavy metal (salt), amine, NH 3Salt | ≥400 | 0 |
Such as, when the ester of the tetradecanoic acid of carbon number 14 and the dodecanol of carbon number 12, organic value is 520 (CH
2, 20 × 26), inorganic value is 60 (-COOR, 60 × 1), therefore IOB=0.12.
In above-mentioned blood modification agent, IOB is about 0.00 ~ about 0.60, is preferably about 0.00 ~ about 0.50, is more preferably about 0.00 ~ about 0.40, and more preferably about 0 ~ about 0.30.This is because, think that the lower then Organic of IOB is higher, higher with the affinity of blood cell.
In this description, " fusing point " refers in differential scanning calorimetric analysis instrument, with during 10 DEG C/min of determination of heating rate be changed to liquid state by solid, shaped time the peak position temperature of endothermic peak.Above-mentioned fusing point such as can use the DSC-60 type DSC determinator of Shimadzu Corporation to measure.
If above-mentioned blood modification agent has the fusing point of less than about 45 DEG C, then can be liquid or solid under room temperature, namely fusing point can be more than about 25 DEG C or lower than about 25 DEG C, and such as can have the fusing point of about-5 DEG C, about-20 DEG C etc.The fusing point of above-mentioned blood modification agent be less than about 45 DEG C according to as described later.
About above-mentioned blood modification agent, there is not lower limit in its fusing point, and preferably its steam forces down.The vapour pressure of above-mentioned blood modification agent is preferably about 0.00 ~ about 0.01Pa at 1 atmospheric pressure and 25 DEG C, is more preferably about 0.000 ~ about 0.001Pa, and more preferably about 0.0000 ~ about 0.0001Pa.If consider, absorbent commodity of the present disclosure and human contact use, then above-mentioned vapour pressure is preferably about 0.00 ~ about 0.01Pa at 1 atmospheric pressure and 40 DEG C, be more preferably about 0.000 ~ about 0.001Pa, and more preferably about 0.0000 ~ about 0.0001Pa, this be due to, if vapour pressure height, gasify in preserving, the amount likely producing blood modification agent reduce, the problem such as foul smell when wearing.
In addition, can according to weather, the fusing point wearing the blood modification agents of applying in a flexible way such as time length.Such as temperature on average is in the region of less than about 10 DEG C, has the blood modification agent of the fusing point of less than about 10 DEG C by adopting, even if after draining menses, when cooled due to environment temperature, blood modification agent also can stably upgrading blood.In addition, when long-time use absorbent commodity, the fusing point of blood modification agent is preferably the high temperature in less than 45 DEG C scopes.This is because, be not vulnerable to antiperspirant, the impact of friction etc. when wearing, when wearing even if long-time, blood modification agent also not easily moves.
The water solubility of 0.00 ~ 0.05g can measure as follows: at 25 DEG C, in the deionized water of 100g, add the sample of 0.05g, leave standstill 24 hours, stir gently as required after 24 hours, then whether gross evaluations sample dissolves, and can measure the water solubility of 0.00 ~ 0.05g thus.It should be noted that, in this description, about water solubility, " dissolving " comprises sample and is dissolved in deionized water completely, forms the situation of homogeneous mixture, and the situation of sample whole milk liquefaction.It should be noted that, " completely " refers to the block that there is not sample in deionized water.
In this technical field, in order to change surface tension of blood etc., promptly absorbing blood, and with the surface on surfactant-coated top layer.But surfactant is high due to usual water solubility, the compatibility being coated with the hydrophilic composition (blood plasma etc.) in the top layer of surfactant and blood is good, exists on the contrary and plays a role to make blood residuals in the tendency on top layer.Above-mentioned blood modification agent due to water solubility low, different from known surfactant, blood can not residue in top layer, and promptly can transfer to absorber.
In this description, being sometimes only called " water solubility " relative to the dissolubility of 100g water at 25 DEG C.
In this description, the concept that " weight average molecular weight " is the compound (compound such as manufactured by successive polymerization, the ester generated by multiple fatty acid and multiple aliphatic monobasic alcohol) and single compound (ester such as generated by a kind of fatty acid and a kind of aliphatic monobasic alcohol) that comprise polydisperse system, comprises N
iindividual molecular weight M
imolecule (i=1 or i=1,2) system in, refer to the M obtained by following formula
w.
M
w＝ΣN
iM
i 2/ΣN
iM
i
In this description, weight average molecular weight refers to the value of the polystyrene conversion obtained by gel permeation chromatography (GPC).As the condition determination of GPC, such as following condition can be listed.
Type: Hitachi High-Technologies Corp. high performance liquid chromatography Lachrom Elite
Chromatographic column: SHODEX KF-801, KF-803 and KF-804 of Showa Denko K. K
Eluent: THF
Flow: 1.0mL/ minute
Sample size: 100 μ L
Detect: RI (differential refractometer)
It should be noted that, the weight average molecular weight recorded in the embodiment of this description is measured by above-mentioned condition.
Above-mentioned blood modification agent is preferably selected from the group be made up of following (i) ~ (iii) and their combination in any:
(i) hydrocarbon;
(ii) have between C-C singly-bound that (ii-1) hydrocarbon part and (ii-2) be inserted into above-mentioned hydrocarbon part, be selected from the group that is made up of carbonyl (-CO-) and oxygen base (-O-) one or more, the compound of identical or different group; With
(iii) there is (iii-1) hydrocarbon part, (iii-2) between the C-C singly-bound being inserted into above-mentioned hydrocarbon part, be selected from the group that is made up of carbonyl (-CO-) and oxygen base (-O-) one or more, identical or different group, and (iii-3) replaces the hydrogen atom of above-mentioned hydrocarbon part, in the group of selecting free carboxyl group (-COOH) and hydroxyl (-OH) to form one or more, the compound of identical or different group.
In this description, " hydrocarbon " refers to the compound by carbon and hydrogen evolution, chain hydrocarbon can be listed, such as paraffin series hydrocarbon (does not comprise double bond and triple bond, also referred to as alkane (alkane)), olefin-based hydrocarbon (comprises a double bond, also referred to as olefine), acetylene system hydrocarbon (comprises a triple bond, also referred to as alkynes (alkyne)) and comprise the hydrocarbon that two or more is selected from the key in the group be made up of double bond and triple bond, and cyclic hydrocarbon, such as aromatic hydrocarbon, ester ring type hydrocarbon.
As above-mentioned hydrocarbon, be preferably chain hydrocarbon and ester ring type hydrocarbon, be more preferably chain hydrocarbon, more preferably paraffin series hydrocarbon, olefin-based hydrocarbon and comprise the hydrocarbon (not comprising triple bond) of two or more double bond, and more preferably paraffin series hydrocarbon.Above-mentioned chain hydrocarbon comprises straight-chain hydrocarbon and branched hydrocarbon.
In the compound of above-mentioned (ii) and (iii), when inserting two or more oxygen base (-O-), each oxygen base (-O-) does not adjoin.Therefore, the compound of above-mentioned (ii) and (iii) does not comprise oxygen base continuous print compound (so-called peroxide).
In addition, in the compound of above-mentioned (iii), the Compound Phase ratio replaced by carboxyl (-COOH) with at least one hydrogen atom of hydrocarbon part, the compound that at least one hydrogen atom of hydrocarbon part is replaced by hydroxyl (-OH) more preferably.This is because, as shown in table 1, the bonding such as metal in carboxyl and menses, inorganic value is significantly elevated to more than 400 by 150, and the blood modification agent therefore with carboxyl in use IOB value is greater than about 0.60, likely reduces with the affinity of blood cell.
Above-mentioned blood modification agent is more preferably selected from the group be made up of following (i ') ~ (iii ') and their combination in any:
(i ') hydrocarbon;
(ii ') have between C-C singly-bound that (ii '-1) hydrocarbon part and (ii '-2) are inserted into above-mentioned hydrocarbon part, be selected from the group that is made up of carbonyl bond (-CO-), ester bond (-COO-), carbonic acid ester bond (-OCOO-) and ehter bond (-O-) one or more, the compound of identical or different key; With
(iii ') there is (iii '-1) hydrocarbon part, between the C-C singly-bound that (iii '-2) are inserted into above-mentioned hydrocarbon part, be selected from the group that is made up of carbonyl bond (-CO-), ester bond (-COO-), carbonic acid ester bond (-OCOO-) and ehter bond (-O-) one or more, identical or different key, and (iii '-3) replace the hydrogen atom of above-mentioned hydrocarbon part, in the group of selecting free carboxyl group (-COOH) and hydroxyl (-OH) to form one or more, the compound of identical or different group.
In the compound of above-mentioned (ii ') and (iii '), insert the situation of two or more identical or different keys, when namely inserting the two or more identical or different key be selected from carbonyl bond (-CO-), ester bond (-COO-), carbonic acid ester bond (-OCOO-) and ehter bond (-O-), each key does not adjoin, and at least clips a carbon atom between each key.
Above-mentioned blood modification agent can more preferably in hydrocarbon part every 10 carbon atoms there is the compound of carbonyl bond (-CO-) less than about 1.8, ester bond (-COO-) less than 2, carbonic acid ester bond (-OCOO-) less than about 1.5, ehter bond (-O-) less than about 6, carboxyl (-COOH) less than about 0.8 and/or hydroxyl (-OH) less than about 1.2.
Above-mentioned blood modification agent is preferably selected from the group be made up of following (A) ~ (F) and their combination in any further:
(A) (A1) there is chain hydrocarbon part and replace above-mentioned chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (A2) chain hydrocarbon part and replace the ester of compound of 1 carboxyl of hydrogen atom of above-mentioned chain hydrocarbon part;
(B) (B1) there is chain hydrocarbon part and replace above-mentioned chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (B2) chain hydrocarbon part and replace the ether of compound of 1 hydroxyl of hydrogen atom of above-mentioned chain hydrocarbon part;
(C) (C1) is containing chain hydrocarbon part with replace the carboxylic acid of 2 ~ 4 carboxyls of hydrogen atom of above-mentioned chain hydrocarbon part, hydroxy acid, alkoxyl acid or oxoacid, has chain hydrocarbon part and replace the ester of compound of 1 hydroxyl of hydrogen atom of above-mentioned chain hydrocarbon part with (C2);
(D) compound being selected from any one key in the group be made up of ehter bond (-O-), carbonyl bond (-CO-), ester bond (-COO-) and carbonic acid ester bond (-OCOO-) between the C-C singly-bound that there is chain hydrocarbon part and be inserted into above-mentioned chain hydrocarbon part;
(E) polyoxy C
2~ C
6aklylene glycol, its Arrcostab or alkyl ether; With
(F) chain hydrocarbon.
Below the blood modification agent of (A) ~ (F) is described in detail.
[(A) (A1) there is chain hydrocarbon part and replace above-mentioned chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (A2) chain hydrocarbon part and replace the ester of compound of 1 carboxyl of hydrogen atom of above-mentioned chain hydrocarbon part]
(A) (A1) there is chain hydrocarbon part and replace above-mentioned chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (A2) chain hydrocarbon part and replace the ester (hereinafter sometimes referred to " compound (A) ") of compound of 1 carboxyl of hydrogen atom of above-mentioned chain hydrocarbon part, as long as have above-mentioned IOB, fusing point and water solubility, then need not the whole hydroxyl of esterification.
There is as (A1) compound (hereinafter sometimes referred to " compound (A1) ") of 2 ~ 4 hydroxyls of the hydrogen atom of chain hydrocarbon part and the above-mentioned chain hydrocarbon part of replacement, can list such as chain hydrocarbon tetrol as alkane tetrol, comprise tetramethylolmethane, chain hydrocarbon triol as alkane triol, comprise glycerol, and chain hydrocarbon glycol as alkane diol, comprise ethylene glycol.
There is as (A2) compound (hereinafter sometimes referred to " compound (A2) ") of 1 carboxyl of the hydrogen atom of chain hydrocarbon part and the above-mentioned chain hydrocarbon part of replacement, compound, such as fatty acid that a hydrogen atom on such as hydrocarbon is replaced by a carboxyl (-COOH) can be listed.
As compound (A), such as (a can be listed
1) the ester, (a of chain hydrocarbon tetrol and at least one fatty acid
2) ester of chain hydrocarbon triol and at least one fatty acid and (a
3) ester of chain hydrocarbon glycol and at least one fatty acid.
[(a
1) ester of chain hydrocarbon tetrol and at least one fatty acid]
As the ester of above-mentioned chain hydrocarbon tetrol and at least one fatty acid, tetramethylolmethane and four esters of fatty acid, the tetramethylolmethane of following formula (2) and three esters of fatty acid, the tetramethylolmethane of following formula (3) and the diester of fatty acid, the tetramethylolmethane of following formula (4) and the monoesters of fatty acid of such as following formula (1) can be listed.
(in formula, R
1~ R
4be respectively chain hydrocarbon)
As the fatty acid (R of ester forming above-mentioned tetramethylolmethane and fatty acid
1cOOH, R
2cOOH, R
3cOOH and R
4cOOH), if the ester of tetramethylolmethane and fatty acid meets the condition of above-mentioned IOB, fusing point and water solubility, be then not particularly limited, such as satisfied fatty acid can be listed, such as C
2~ C
30satisfied fatty acid, such as acetic acid (C
2) (C
2represent carbon number, be equivalent to R
1c, R
2c, R
3c or R
4the carbon number of C, identical below), propanoic acid (C
3), butanoic acid (C
4) and isomer as 2 Methylpropionic acid (C
4), valeric acid (C
5) and isomer as 2-Methyl Butyric Acid (C
5) and PA (C
5), caproic acid (C
6), enanthic acid (C
7), sad (C
8) and isomer as 2 ethyl hexanoic acid (C
8), n-nonanoic acid (C
9), capric acid (C
10), dodecylic acid (C
12), tetradecanoic acid (C
14), hexadecanoic acid (C
16), heptadecanoic acid (C
17), octadecanoid acid (C
18), arachic acid (C
20), behenic acid (C
22), lignoceric acid (C
24), hexacosoic acid (C
26), octocosoic acid (C
28), melissic acid (C
30) etc., and their isomer (except above-mentioned example).
In addition, above-mentioned fatty acid also can be unsaturated fatty acid.As above-mentioned unsaturated fatty acid, such as C can be listed
3~ C
20unsaturated fatty acid, such as monounsaturated fatty acid such as .beta.-methylacrylic acid (C
4), myristoleic acid (C
14), palmitoleic acid (C
16), oleic acid (C
18), elaidic acid (C
18), vaccenic acid (C
18), cis 9-eicosenoic acid (C
20), eicosenoic acid (C
20) etc., two unsaturated fatty acids are linoleic acid (C such as
18), eicosadienoic acid (C
20) etc., three unsaturated fatty acids such as linolenic acid is as alpha-linolenic acid (C
18) and gamma-Linolenic acid (C
18), pinolenic acid (pinolenic acid) (C
18), eleostearic acid is as alpha-eleostearic acid (C
18) and β-eleostearic acid (C
18), Mead acid (Mead acid) (C
20), dihomo-gamma-linolenic acid (C
20), eicosatrienoic acid (C
20) etc., four unsaturated fatty acids are parinaric acid (stearidonic acid) (C such as
20), arachidonic acid (C
20), eicosatetraenoic acid (C
20) etc., five unsaturated fatty acids are 18 carbon 5 alkene acids (bosseopentaenoic acid) (C such as
18), eicosapentaenoic acid (C
20) etc., and their partial hydrogenation thing.
As the ester of above-mentioned tetramethylolmethane and fatty acid, if consider the probability of modification because oxidation waits, be then preferably derived from the tetramethylolmethane of satisfied fatty acid and the ester of the ester of fatty acid, i.e. tetramethylolmethane and satisfied fatty acid.In addition, as the ester of above-mentioned tetramethylolmethane and fatty acid, in order to reduce IOB, form hydrophobicity further, be preferably diester, three esters or four esters, be more preferably three esters or four esters, and more preferably four esters.
In four esters of above-mentioned tetramethylolmethane and fatty acid, the carbon number forming the fatty acid of four esters of tetramethylolmethane and fatty acid amounts to, i.e. R in above-mentioned formula (1)
1c, R
2c, R
3c and R
4when the carbon number of C part adds up to 15, IOB is 0.60.Therefore, in four esters of above-mentioned tetramethylolmethane and fatty acid, when above-mentioned carbon number adds up to about more than 15, meet the condition that IOB is about 0.00 ~ about 0.60.For four esters of above-mentioned tetramethylolmethane and fatty acid, such as tetramethylolmethane and caproic acid (C can be listed
6), enanthic acid (C
7), sad (C
8) as 2 ethyl hexanoic acid (C
8), n-nonanoic acid (C
9), capric acid (C
10) and/or dodecylic acid (C
12) four esters.
In three esters of above-mentioned tetramethylolmethane and fatty acid, the carbon number forming the fatty acid of three esters of tetramethylolmethane and fatty acid amounts to, i.e. R in above-mentioned formula (2)
1c, R
2c and R
3when the carbon number of C part adds up to 19, IOB is 0.58.Therefore, in three esters of above-mentioned tetramethylolmethane and fatty acid, when the carbon number of fatty acid adds up to about more than 19, meet the condition that IOB is about 0.00 ~ about 0.60.
In the diester of above-mentioned tetramethylolmethane and fatty acid, the carbon number forming the fatty acid of the diester of tetramethylolmethane and fatty acid amounts to, i.e. R in above-mentioned formula (3)
1c and R
2when the carbon number of C part adds up to 22, IOB is 0.59.Therefore, in the diester of above-mentioned tetramethylolmethane and fatty acid, when the carbon number of fatty acid adds up to about more than 22, meet the condition that IOB is about 0.00 ~ about 0.60.
In the monoesters of above-mentioned tetramethylolmethane and fatty acid, form the carbon number of the fatty acid of the monoesters of tetramethylolmethane and fatty acid, i.e. R in above-mentioned formula (4)
1when the carbon number of C part is 25, IOB is 0.60.Therefore, in the monoesters of above-mentioned tetramethylolmethane and fatty acid, when the carbon number of fatty acid is about more than 25, meet the condition that IOB is about 0.00 ~ about 0.60.It should be noted that, during above-mentioned calculating, do not consider the impact of double bond, triple bond, different branching and tertiary branching.
As the commercially available product of the ester of above-mentioned tetramethylolmethane and fatty acid, can list (above Japan Oil Co systems) such as UNISTARH-408BRS, H-2408BRS-22 (melange).
[(a
2) ester of chain hydrocarbon triol and at least one fatty acid]
As the ester of above-mentioned chain hydrocarbon triol and at least one fatty acid, the glycerol of such as following formula (5) and three esters of fatty acid, the glycerol of following formula (6) and the glycerol of the diester of fatty acid and following formula (7) and the monoesters of fatty acid can be listed.
(in formula, R
5~ R
7be respectively chain hydrocarbon).
As the fatty acid (R of ester forming above-mentioned glycerol and fatty acid
5cOOH, R
6cOOH and R
7cOOH), if the ester of glycerol and fatty acid meets the condition of above-mentioned IOB, fusing point and water solubility, be not particularly limited, such as " (a can be listed
1) ester of chain hydrocarbon tetrol and at least one fatty acid " and in fatty acid, i.e. satisfied fatty acid and the unsaturated fatty acid enumerated; if consider the likely modification because oxidation waits, be then preferably derived from the glycerol of satisfied fatty acid and the ester of the ester of fatty acid, i.e. glycerol and satisfied fatty acid.
In addition, as the ester of above-mentioned glycerol and fatty acid, in order to reduce IOB, form hydrophobicity further, be preferably diester or three esters, and be more preferably three esters.
Three esters of above-mentioned glycerol and fatty acid, also referred to as triglyceride, can list such as glycerol and sad (C
8) three esters, glycerol and capric acid (C
10) three esters, glycerol and dodecylic acid (C
12) three esters, glycerol and two or three three esters of fatty acid and their mixture.
As three esters of above-mentioned glycerol and two or more fatty acids, such as glycerol and sad (C can be listed
8) and capric acid (C
10) three esters, glycerol and sad (C
8), capric acid (C
10) and dodecylic acid (C
12) three esters, glycerol and sad (C
8), capric acid (C
10), dodecylic acid (C
12), tetradecanoic acid (C
14), hexadecanoic acid (C
16) and octadecanoid acid (C
18) three esters etc.
As three esters of above-mentioned glycerol and fatty acid, in order to make fusing point be less than about 45 DEG C, preferably forming glycerol and amounting to the carbon number of the fatty acid of three esters of fatty acid, be i.e. the middle R of formula (5)
5c, R
6c and R
7the carbon number of C part adds up to about less than 40.
In addition, in three esters of above-mentioned glycerol and fatty acid, the carbon number forming the fatty acid of three esters of glycerol and fatty acid amounts to, i.e. R in formula (5)
5c, R
6c and R
7when the carbon number of C part adds up to 12, IOB is 0.60.Therefore, in three esters of above-mentioned glycerol and fatty acid, when the carbon number of fatty acid adds up to about more than 12, meet the condition that IOB is about 0.00 ~ about 0.60.Three esters of above-mentioned glycerol and fatty acid are so-called fat, for forming the composition of human body, therefore consider preferably from safety point.
As the commercially available product of three esters of above-mentioned glycerol and fatty acid, three coconut oil fat acid glycerides, NA36, PANACET 800, PANACET 800B and PANACET 810S and three C2L fatty acid oil glyceride and three CL fatty acid oil glyceride (above Japan Oil Co system) etc. can be listed.
The diester of above-mentioned glycerol and fatty acid, also referred to as diglyceride, can list such as glycerol and capric acid (C
10) diester, glycerol and dodecylic acid (C
12) diester, glycerol and hexadecanoic acid (C
16) the diester of diester, glycerol and two kinds of fatty acids, and their mixture.
In the diester of above-mentioned glycerol and fatty acid, the carbon number forming the fatty acid of the diester of glycerol and fatty acid amounts to, i.e. R in formula (6)
5c and R
6when the carbon number of C part adds up to 16, IOB is 0.58.Therefore, in the diester of above-mentioned glycerol and fatty acid, when the carbon number of fatty acid adds up to about more than 16, meet the condition that IOB is about 0.00 ~ about 0.60.
The monoesters of above-mentioned glycerol and fatty acid, also referred to as glyceryl monoacetate, can list the arachic acid (C of such as glycerol
20) monoesters, glycerol behenic acid (C
22) monoesters etc.In the monoesters of above-mentioned glycerol and fatty acid, form the carbon number of the fatty acid of the monoesters of glycerol and fatty acid, i.e. R in formula (7)
5when the carbon number of C part is 19, IOB is 0.59.Therefore, in the monoesters of above-mentioned glycerol and fatty acid, when the carbon number of fatty acid is about more than 19, meet the condition that IOB is about 0.00 ~ about 0.60.
[(a
3) ester of chain hydrocarbon glycol and at least one fatty acid]
As the ester of above-mentioned chain hydrocarbon glycol and at least one fatty acid, such as C can be listed
2~ C
6chain hydrocarbon glycol such as C
2~ C
6dihydroxylic alcohols and the monoesters of fatty acid or diester, described C
2~ C
6dihydroxylic alcohols is such as ethylene glycol, propylene glycol, butanediol, pentanediol or hexanediol.
Specifically, as the ester of above-mentioned chain hydrocarbon glycol and at least one fatty acid, the C of such as following formula (8) can be listed
2~ C
6the C of the diester of dihydroxylic alcohols and fatty acid and following formula (9)
2~ C
6the monoesters of dihydroxylic alcohols and fatty acid:
R
8COOC
kH
2kOCOR
9(8)
(in formula, k is the integer of 2 ~ 6, and R
8and R
9be respectively chain hydrocarbon),
R
8COOC
kH
2kOH (9)
(in formula, k is the integer of 2 ~ 6, and R
8for chain hydrocarbon).
Above-mentioned C
2~ C
6in the ester of dihydroxylic alcohols and fatty acid, (in formula (8) and formula (9), be equivalent to R as answering the fatty acid of esterification
8cOOH and R
9cOOH), if C
2~ C
6the ester of dihydroxylic alcohols and fatty acid meets the condition of above-mentioned IOB, fusing point and water solubility, be then not particularly limited, and can list such as " (a
1) ester of chain hydrocarbon tetrol and at least one fatty acid " and in fatty acid, i.e. satisfied fatty acid and the unsaturated fatty acid enumerated, if consider the likely modification because oxidation waits, be then preferably satisfied fatty acid.
In the diester of the butanediol (k=4) shown in formula (8) and fatty acid, R
8c and R
9when the carbon number of C part adds up to 6, IOB is 0.60.Therefore, the butanediol (k=4) shown in formula (8), with the diester of fatty acid, when above-mentioned carbon number adds up to about more than 6, meets the condition that IOB is about 0.00 ~ about 0.60.In addition, in the monoesters of the ethylene glycol (k=2) shown in formula (9) and fatty acid, R
8when the carbon number of C part is 12, IOB is 0.57.Therefore, the ethylene glycol (k=2) shown in formula (9), with the monoesters of fatty acid, when the carbon number of fatty acid is about more than 12, meets the condition that IOB is about 0.00 ~ about 0.60.
As above-mentioned C
2~ C
6the ester of dihydroxylic alcohols and fatty acid, if consider the likely modification because oxidation waits, is then preferably derived from the C of satisfied fatty acid
2~ C
6the ester of dihydroxylic alcohols and fatty acid, i.e. C
2~ C
6the ester of dihydroxylic alcohols and satisfied fatty acid.
In addition, as above-mentioned C
2~ C
6the ester of dihydroxylic alcohols and fatty acid, in order to reduce IOB, form hydrophobicity further, is preferably derived from the dihydroxylic alcohols of the many dihydroxylic alcohols of carbon number and the ester of fatty acid, such as, is derived from the dihydroxylic alcohols of butanediol, pentanediol or hexanediol and the ester of fatty acid.
And then, as above-mentioned C
2~ C
6the ester of dihydroxylic alcohols and fatty acid, in order to reduce IOB, form hydrophobicity further, is preferably diester.As above-mentioned C
2~ C
6the commercially available product of the ester of dihydroxylic alcohols and fatty acid, can list such as COMPOL BL, COMPOL BS (above Japan Oil Co system) etc.
[(B) (B1) there is chain hydrocarbon part and replace above-mentioned chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (B2) chain hydrocarbon part and replace the ether of compound of 1 hydroxyl of hydrogen atom of above-mentioned chain hydrocarbon part]
(B) (B1) there is chain hydrocarbon part and replace above-mentioned chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (B2) chain hydrocarbon part and replace the ether (hereinafter sometimes referred to " compound (B) ") of compound of 1 hydroxyl of hydrogen atom of above-mentioned chain hydrocarbon part, as long as have above-mentioned IOB, fusing point and water solubility, then need not the whole hydroxyl of etherificate.
There is as (B1) compound of 2 ~ 4 hydroxyls of the hydrogen atom of chain hydrocarbon part and the above-mentioned chain hydrocarbon part of replacement, the example enumerated as compound (A1) in " compound (A) " can be listed, such as tetramethylolmethane, glycerol and dihydroxylic alcohols.
There is as (B2) compound (hereinafter sometimes referred to " compound (B2) ") of 1 hydroxyl of the hydrogen atom of chain hydrocarbon part and the above-mentioned chain hydrocarbon part of replacement, the compound that 1 hydrogen atom that can list such as hydrocarbon is replaced by 1 hydroxyl (-OH), such as aliphatic monobasic alcohol, comprises representative examples of saturated aliphatic monohydric alcohol and unsaturated aliphatic monohydric alcohol.
As above-mentioned representative examples of saturated aliphatic monohydric alcohol, such as C can be listed
1~ C
20representative examples of saturated aliphatic monohydric alcohol, such as, methanol (C
1) (C
1represent carbon number, identical below), ethanol (C
2), propanol (C
3) and isomer comprise isopropyl alcohol (C
3), butanols (C
4) and isomer comprise sec-butyl alcohol (C
4) and the tert-butyl alcohol (C
4), amylalcohol (C
5), hexanol (C
6), enanthol (C
7), capryl alcohol (C
8) and isomer comprise 2-Ethylhexyl Alcohol (C
8), nonyl alcohol (C
9), decanol (C
10), dodecanol (C
12), tetradecanol (C
14), hexadecanol (C
16), heptadecanol (C
17), octadecanol (C
18) and EICOSANOL (C
20), and their isomer do not enumerated.
As above-mentioned unsaturated aliphatic monohydric alcohol, the unsaturated aliphatic monohydric alcohol of 1 C-C singly-bound C=C double bond displacement of above-mentioned representative examples of saturated aliphatic monohydric alcohol can be listed, such as oleyl alcohol, such as commercially available with the title of RIKACOL series and UNJECOL series by New Japan Chem Co., Ltd.
As compound (B), such as (b can be listed
1) ether of chain hydrocarbon tetrol and at least one aliphatic monobasic alcohol, as monoether, diether, three ethers and tetraether, preferred diether, three ethers and tetraether, more preferably three ethers and tetraether, and preferred tetraether further, (b
2) ether of chain hydrocarbon triol and at least one aliphatic monobasic alcohol, as monoether, diether and three ethers, preferred diether and three ethers, and more preferably three ethers, and (b
3) ether of chain hydrocarbon glycol and at least one aliphatic monobasic alcohol, as monoether and diether, and preferred diether.
As the ether of above-mentioned chain hydrocarbon tetrol and at least one aliphatic monobasic alcohol, the tetraether of the tetramethylolmethane of such as following formula (10) ~ (13) and aliphatic monobasic alcohol, three ethers, diether and monoether can be listed.
(R in formula
10~ R
13be respectively chain hydrocarbon.)
As the ether of above-mentioned chain hydrocarbon triol and at least one aliphatic monobasic alcohol, three ethers of the glycerol of such as following formula (14) ~ (16) and aliphatic monobasic alcohol, diether and monoether can be listed.
(R in formula
14~ R
16be respectively chain hydrocarbon.)
As the ether of above-mentioned chain hydrocarbon glycol and at least one aliphatic monobasic alcohol, the C of following formula (17) can be listed
2~ C
6the diether of dihydroxylic alcohols and aliphatic monobasic alcohol, the C of following formula (18)
2~ C
6the monoether of dihydroxylic alcohols and aliphatic monobasic alcohol:
R
17OC
nH
2nOR
18(17)
(in formula, n is the integer of 2 ~ 6, and R
17and R
18be respectively chain hydrocarbon),
R
17OC
nH
2nOH (18)
(in formula, n is the integer of 2 ~ 6, and R
17for chain hydrocarbon).
In the tetraether of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, the carbon number forming the aliphatic monobasic alcohol of the tetraether of tetramethylolmethane and aliphatic monobasic alcohol amounts to, i.e. R in above-mentioned formula (10)
10, R
11, R
12and R
13when the carbon number of part adds up to 4, IOB is 0.44.Therefore, in the tetraether of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol adds up to about more than 4, meet the condition that IOB is about 0.00 ~ about 0.60.
In three ethers of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, the carbon number forming the aliphatic monobasic alcohol of three ethers of tetramethylolmethane and aliphatic monobasic alcohol amounts to, i.e. R in above-mentioned formula (11)
10, R
11and R
12when the carbon number of part adds up to 9, IOB is 0.57.Therefore, in three ethers of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol adds up to about more than 9, meet the condition that IOB is about 0.00 ~ about 0.60.
In the diether of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, the carbon number forming the aliphatic monobasic alcohol of the diether of tetramethylolmethane and aliphatic monobasic alcohol amounts to, i.e. R in above-mentioned formula (12)
10and R
11when the carbon number of part adds up to 15, IOB is 0.60.Therefore, in the diether of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol adds up to about more than 15, meet the condition that IOB is about 0.00 ~ about 0.60.
In the monoether of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, form the carbon number of the aliphatic monobasic alcohol of the monoether of tetramethylolmethane and aliphatic monobasic alcohol, i.e. R in above-mentioned formula (13)
10when the carbon number of part is 22, IOB is 0.59.Therefore, in the monoether of above-mentioned tetramethylolmethane and aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol is about more than 22, meet the condition that IOB is about 0.00 ~ about 0.60.
In addition, in three ethers of above-mentioned glycerol and aliphatic monobasic alcohol, the carbon number forming the aliphatic monobasic alcohol of three ethers of glycerol and aliphatic monobasic alcohol amounts to, i.e. R in formula (14)
14, R
15and R
16when the carbon number of part adds up to 3, IOB is 0.50.Therefore, in three ethers of above-mentioned glycerol and aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol adds up to about more than 3, meet the condition that IOB is about 0.00 ~ about 0.60.
In the diether of above-mentioned glycerol and aliphatic monobasic alcohol, the carbon number forming the aliphatic monobasic alcohol of the diether of glycerol and aliphatic monobasic alcohol amounts to, i.e. R in formula (15)
14and R
15when the carbon number of part adds up to 9, IOB is 0.58.Therefore, in the diether of above-mentioned glycerol and aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol adds up to about more than 9, meet the condition that IOB is about 0.00 ~ about 0.60.
In the monoether of above-mentioned glycerol and aliphatic monobasic alcohol, form the carbon number of the aliphatic monobasic alcohol of the monoether of glycerol and aliphatic monobasic alcohol, i.e. R in formula (16)
14when the carbon number of part is 16, IOB is 0.58.Therefore, in the monoether of above-mentioned glycerol and aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol is about more than 16, meet the condition that IOB is about 0.00 ~ about 0.60.
In the diether of the butanediol (n=4) shown in formula (17) and aliphatic monobasic alcohol, R
17and R
18when the carbon number of part adds up to 2, IOB is 0.33.Therefore, the butanediol (n=4) shown in formula (17), with the diether of aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol adds up to more than 2, meets the condition that IOB is about 0.00 ~ about 0.60.In addition, in the monoether of the ethylene glycol (n=2) shown in formula (18) and aliphatic monobasic alcohol, R
17when the carbon number of part is 8, IOB is 0.60.Therefore, the ethylene glycol (n=2) shown in formula (18), with the monoether of aliphatic monobasic alcohol, when the carbon number of aliphatic monobasic alcohol is about more than 8, meets the condition that IOB is about 0.00 ~ about 0.60.
As compound (B), can by the presence of acid catalyst compound (B1) and compound (B2) dehydrating condensation being generated.
[(C) (C1) is containing chain hydrocarbon part and replace the carboxylic acid of 2 ~ 4 carboxyls of hydrogen atom of above-mentioned chain hydrocarbon part, hydroxy acid, alkoxyl acid or oxoacid, has chain hydrocarbon part and replace the ester of compound of 1 hydroxyl of hydrogen atom of above-mentioned chain hydrocarbon part with (C2)]
(C) (C1) is containing chain hydrocarbon part with replace the carboxylic acid of 2 ~ 4 carboxyls of hydrogen atom of above-mentioned chain hydrocarbon part, hydroxy acid, alkoxyl acid or oxoacid, with (C2), there is chain hydrocarbon part and replace the ester (hereinafter sometimes referred to " compound (C) ") of compound of 1 hydroxyl of hydrogen atom of above-mentioned chain hydrocarbon part, as long as have above-mentioned IOB, fusing point and water solubility, then need not the whole carboxyl of esterification.
As (C1) containing the carboxylic acid of chain hydrocarbon part with 2 ~ 4 carboxyls of the hydrogen atom of the above-mentioned chain hydrocarbon part of replacement, hydroxy acid, alkoxyl acid or oxoacid (hereinafter sometimes referred to " compound (C1) "), the chain alkylene dicarboxylate such as with 2 ~ 4 carboxyls can be listed, as chain hydrocarbon dicarboxylic acids comprises alkane dicarboxylic acids, as ethanedioic acid, malonic acid, succinic acid, 1,3-propanedicarboxylic acid, adipic acid, 1,5-pentanedicarboxylic acid., suberic acid, Azelaic Acid and decanedioic acid, chain hydrocarbon tricarboxylic acids comprises alkane tricarboxylic acids as tricarballylic acid, fourth tricarboxylic acids, penta tricarboxylic acids, own tricarboxylic acids, heptan tricarboxylic acids, pungent tricarboxylic acids, the ninth of the ten Heavenly Stems tricarboxylic acids and the last of the ten Heavenly stems tricarboxylic acids, and chain hydrocarbon tetrabasic carboxylic acid comprises alkane tetrabasic carboxylic acid, as BTCA, pentane tetrabasic carboxylic acid, hexane tetrabasic carboxylic acid, heptane tetrabasic carboxylic acid, octane tetrabasic carboxylic acid, nonane tetrabasic carboxylic acid and decane tetrabasic carboxylic acid.
In addition, compound (C1) comprises the chain hydrocarbon hydroxy acid with 2 ~ 4 carboxyls, as malic acid, tartaric acid, citric acid and 1-Hydroxy-1,2,3-propanetricarboxylic acid. etc., has the chain hydrocarbon alkoxyl acid of 2 ~ 4 carboxyls, as O-acetyl tributyl citrate, and there is the chain hydrocarbon oxoacid of 2 ~ 4 carboxyls.There is as (C2) compound of 1 hydroxyl of the hydrogen atom of chain hydrocarbon part and the above-mentioned chain hydrocarbon part of replacement, the example listed in the item of " compound (B) " can be listed, such as aliphatic monobasic alcohol.
As compound (C), (c can be listed
1) there is the ester of the chain hydrocarbon tetrabasic carboxylic acid of 4 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol, such as monoesters, diester, three esters and four esters, preferred diester, three esters and four esters, more preferably three esters and four esters, and preferred four esters further, (c
2) there is the ester of the chain hydrocarbon tricarboxylic acids of 3 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol, such as monoesters, diester and three esters, preferred diester and three esters, and more preferably three esters, and (c
3) there is the ester of the chain hydrocarbon dicarboxylic acids of 2 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol, such as monoesters and diester, preferred diester.As the example of compound (C), dioctyl adipate, O-tributyl 2-acetylcitrate etc. can be listed, and commercially available.
[(D) has chain hydrocarbon part and is inserted into the compound being selected from any one key in the group be made up of ehter bond (-O-), carbonyl bond (-CO-), ester bond (-COO-) and carbonic acid ester bond (-OCOO-) between the C-C singly-bound of above-mentioned chain hydrocarbon part]
The compound (hereinafter sometimes referred to " compound (D) ") being selected from any one key in the group be made up of ehter bond (-O-), carbonyl bond (-CO-), ester bond (-COO-) and carbonic acid ester bond (-OCOO-) between the C-C singly-bound having chain hydrocarbon part as (D) and be inserted into above-mentioned chain hydrocarbon part, can list (d
1) the ether, (d of aliphatic monobasic alcohol and aliphatic monobasic alcohol
2) dialkyl ketone, (d
3) ester of fatty acid and aliphatic monobasic alcohol and (d
4) dialkyl carbonate.
[(d
1) ether of aliphatic monobasic alcohol and aliphatic monobasic alcohol]
As the ether of above-mentioned aliphatic monobasic alcohol and aliphatic monobasic alcohol, the compound with following formula (19) can be listed:
R
19OR
20(19)
(in formula, R
19and R
20be respectively chain hydrocarbon).
As the aliphatic monobasic alcohol forming above-mentioned ether, (formula is equivalent to R in (19)
19oH and R
20oH), if above-mentioned ether meets the condition of above-mentioned IOB, fusing point and water solubility, be then not particularly limited, the aliphatic monobasic alcohol enumerated in " compound (B) " item can be listed such as.
In the ether of aliphatic monobasic alcohol and aliphatic monobasic alcohol, form R in carbon number total, the i.e. above-mentioned formula (19) of the aliphatic monobasic alcohol of this ether
19and R
20when the carbon number of part adds up to 2, IOB is 0.50, therefore, if this carbon number adds up to about more than 2, then meets the condition of above-mentioned IOB.But when above-mentioned carbon number adds up to about 6, water solubility is high, be about 2g, have problems from the viewpoint of vapour pressure.In order to meet the condition that water solubility is about 0.00 ~ about 0.05g, preferred above-mentioned carbon number adds up to about more than 8.
[(d
2) dialkyl ketone]
As above-mentioned dialkyl ketone, the compound with following formula (20) can be listed:
R
21COR
22(20)
(in formula, R
21and R
22be respectively alkyl).
In above-mentioned dialkyl ketone, R
21and R
22carbon number when adding up to 5, IOB is 0.54, therefore, if this carbon number adds up to about more than 5, then meets the condition of above-mentioned IOB.But when above-mentioned carbon number adds up to about 5, water solubility is high, be about 2g.Therefore, in order to meet the condition that water solubility is about 0.00 ~ about 0.05g, preferred above-mentioned carbon number adds up to about more than 8.In addition, if consider vapour pressure, then above-mentioned carbon number is preferably about more than 10, and is more preferably about more than 12.It should be noted that, when above-mentioned carbon number adds up to about 8, such as butyl ketone, fusing point is about-50 DEG C, vapour pressure is about 230Pa at 20 DEG C.About above-mentioned dialkyl ketone, except commercially available, such as with chromic acid etc., secondary alcohol oxidation can also be obtained by known method.
[(d
3) ester of fatty acid and aliphatic monobasic alcohol]
As the ester of above-mentioned fatty acid and aliphatic monobasic alcohol, the compound such as with following formula (21) can be listed:
R
23COOR
24(21)
(in formula, R
23and R
24be respectively chain hydrocarbon).
As the fatty acid forming above-mentioned ester, (formula is equivalent to R in (21)
23cOOH), such as " (a can be listed
1) ester of chain hydrocarbon tetrol and at least one fatty acid " and in fatty acid, i.e. satisfied fatty acid or the unsaturated fatty acid enumerated, if consider likely due to modifications such as oxidations, be preferably satisfied fatty acid.As the aliphatic monobasic alcohol forming above-mentioned ester, (formula is equivalent to R in (21)
24oH), the aliphatic monobasic alcohol enumerated in " compound (B) " item can be listed such as.
It should be noted that, in the ester of above-mentioned fatty acid and aliphatic monobasic alcohol, the carbon number total of fatty acid and aliphatic monobasic alcohol and the middle R of formula (21)
23c and R
24when the carbon number of part adds up to 5, IOB is 0.60, therefore, and R
23c and R
24when the carbon number of part adds up to about more than 5, meet the condition of above-mentioned IOB.But such as the butyl acetate that above-mentioned carbon number adds up to 6, vapour pressure is high, more than 2000Pa.Therefore, if consider vapour pressure, then above-mentioned carbon number amounts to and is preferably about more than 12.It should be noted that, if above-mentioned carbon number adds up to about more than 11, then can meet the condition that water solubility is about 0.00 ~ about 0.05g.
As the example of the ester of above-mentioned fatty acid and aliphatic monobasic alcohol, such as dodecylic acid (C can be listed
12) and dodecanol (C
12) ester, tetradecanoic acid (C
14) and dodecanol (C
12) ester etc., as the commercially available product of the ester of above-mentioned fatty acid and aliphatic monobasic alcohol, such as ELECTOL WE20 and ELECTOL WE40 (above Japan Oil Co system) can be listed.
[(d
4) dialkyl carbonate]
As above-mentioned dialkyl carbonate, the compound with following formula (22) can be listed:
R
25OC(＝O)OR
26(22)
(formula, R
25and R
26be respectively alkyl).
In above-mentioned dialkyl carbonate, R
25and R
26carbon number when adding up to 6, IOB is 0.57, therefore, if R
25and R
26carbon number add up to about more than 6, then meet the condition of IOB.If consider water solubility, then R
25and R
26carbon number amount to and be preferably about more than 7, and be more preferably about more than 9.About above-mentioned dialkyl carbonate, except commercially available, can also be synthesized with the reaction of alcohol or alcoholates and the reaction of Disilver carbonate and alkyl iodide by the reaction of phosgene and alcohol, chlorination formic acid esters.
[(E) polyoxy C
2~ C
6aklylene glycol, its ester or ether]
As above-mentioned polyoxy C
2~ C
6aklylene glycol, its ester or ether (hereinafter sometimes referred to compound (E)), can list (e
1) polyoxy C
2~ C
6aklylene glycol, (e
2) polyoxy C
2~ C
6the ester of aklylene glycol and at least one fatty acid, (e
3) polyoxy C
2~ C
6the ether of aklylene glycol and at least one aliphatic monobasic alcohol, (e
4) polyoxy C
2~ C
6the ester of aklylene glycol and chain hydrocarbon tetrabasic carboxylic acid, chain hydrocarbon tricarboxylic acids or chain hydrocarbon dicarboxylic acids, and (e
5) polyoxy C
2~ C
6the ether of aklylene glycol and chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol.Below be described.
[(e
1) polyoxy C
2~ C
6aklylene glycol]
Above-mentioned polyoxy C
2~ C
6aklylene glycol refers to i) to have and is selected from by oxygen base C
2~ C
6alkylene backbone, any one skeleton in the group of i.e. oxygen base ethylidene skeleton, oxygen base propylidene skeleton, oxygen base butylidene skeleton, oxygen base pentylidene skeleton and oxygen base hexylidene skeleton composition and two ends have the homopolymer of hydroxyl, ii) have be selected from two or more skeleton in above-mentioned group and two ends have the block copolymer of hydroxyl or iii) have and be selected from two or more skeleton in above-mentioned group and two ends have the random copolymer of hydroxyl.
Above-mentioned oxygen base C
2~ C
6alkylene backbone is from reduction polyoxy C
2~ C
6the viewpoint of the IOB of aklylene glycol is considered, is preferably oxygen base propylidene skeleton, oxygen base butylidene skeleton, oxygen base pentylidene skeleton or oxygen base hexylidene skeleton, is more preferably oxygen base butylidene skeleton, oxygen base pentylidene skeleton or oxygen base hexylidene skeleton.
Above-mentioned polyoxy C
2~ C
6aklylene glycol can pass through following formula (23) and represent:
HO-(C
mH
2mO)
n-H (23)
(in formula, m is the integer of 2 ~ 6).
It should be noted that, the present inventor confirms, Polyethylene Glycol (being equivalent to the homopolymer of m=2 in formula (23)), when n >=45 (weight average molecular weight exceedes about 2000), meet the condition of the IOB of about 0.00 ~ about 0.60, but even if when weight average molecular weight exceedes about 4000, also do not meet the condition of water solubility.Therefore think, (e
1) polyoxy C
2~ C
6aklylene glycol does not comprise the homopolymer of ethylene glycol, and ethylene glycol should to be included in (e with the block copolymer or random copolymer form of other dihydroxylic alcohols
1) polyoxy C
2~ C
6aklylene glycol.
Therefore, the homopolymer of formula (23) can comprise the homopolymer of propylene glycol, butanediol, pentanediol or hexanediol.Thus, in formula (23), m is about 3 ~ about 6, and is more preferably about 4 ~ about 6, and n is more than 2.
In above-mentioned formula (23), the value of n is polyoxy C
2~ C
6aklylene glycol has the value that the IOB of about 0.00 ~ about 0.60, the fusing point of less than about 45 DEG C and the water 100g relative to 25 DEG C are the water solubility of about 0.00 ~ about 0.05g.Such as, when formula (23) is for polypropylene glycol (homopolymer of m=3), during n=12, IOB is 0.58.Therefore, when formula (23) is for polypropylene glycol (homopolymer of m=3), during m >=about 12, the condition of above-mentioned IOB is met.In addition, when formula (23) is for polytetramethylene glycol (homopolymer of m=4), during n=7, IOB is 0.57.Therefore, when formula (23) is for polytetramethylene glycol (homopolymer of m=4), during n >=about 7, the condition of above-mentioned IOB is met.
From the viewpoint of IOB, fusing point and water solubility, polyoxy C
2~ C
6the weight average molecular weight of aklylene glycol is preferably in the scope of about 200 ~ about 10000, is more preferably in the scope of about 250 ~ about 8000, and is preferably in further in the scope of about 250 ~ about 5000.In addition, from the viewpoint of IOB, fusing point and water solubility, polyoxy C
3the weight average molecular weight of aklylene glycol and polypropylene glycol is preferably in the scope of about 1000 ~ about 10000, is more preferably in the scope of about 3000 ~ about 8000, and is preferably in further in the scope of about 4000 ~ about 5000.This is because, above-mentioned Weight-average molecular quantity not sufficient about 1000 time, water solubility does not satisfy condition, and it is larger to there is weight average molecular weight, particularly the tendency that more raises of the whiteness on absorber transfer velocity and top layer.
As above-mentioned polyoxy C
2~ C
6the commercially available product of aklylene glycol, can list such as UNIOL (trade mark) D-1000, D1200, D-2000, D-3000, D-4000, PB-500, PB-700, PB-1000 and PB-2000 (above Japan Oil Co system).
[(e
2) polyoxy C
2~ C
6the ester of aklylene glycol and at least one fatty acid]
As above-mentioned polyoxy C
2~ C
6the ester of aklylene glycol and at least one fatty acid, can list " (e
1) polyoxy C
2~ C
6aklylene glycol " the polyoxy C that illustrates in item
2~ C
6the one or both of the OH end of aklylene glycol by the ester of fatty acid esterification, i.e. monoesters and diester.
As polyoxy C
2~ C
6answer the fatty acid of esterification in the ester of aklylene glycol and at least one fatty acid, such as " (a can be listed
1) ester of chain hydrocarbon tetrol and at least one fatty acid " and in the fatty acid enumerated, i.e. satisfied fatty acid or unsaturated fatty acid, if consider the likely modification because oxidation waits, is then preferably satisfied fatty acid.As above-mentioned polyoxy C
2~ C
6the commercially available product of the ester of aklylene glycol and fatty acid, can list such as WILLBRITE cp9 (Japan Oil Co's system).
[(e
3) polyoxy C
2~ C
6the ether of aklylene glycol and at least one aliphatic monobasic alcohol]
As above-mentioned polyoxy C
2~ C
6the ether of aklylene glycol and at least one aliphatic monobasic alcohol, can list " (e
1) polyoxy C
2~ C
6aklylene glycol " the polyoxy C that illustrates in item
2~ C
6the one or both of the OH end of aklylene glycol by the ether of aliphatic monobasic alcohol etherificate, i.e. monoether and diether.As polyoxy C
2~ C
6answer the aliphatic monobasic alcohol of etherificate in the ether of aklylene glycol and at least one aliphatic monobasic alcohol, the aliphatic monobasic alcohol enumerated in " compound (B) " item can be listed such as.
[(e
4) polyoxy C
2~ C
6the ester of aklylene glycol and chain hydrocarbon tetrabasic carboxylic acid, chain hydrocarbon tricarboxylic acids or chain hydrocarbon dicarboxylic acids]
As above-mentioned polyoxy C
2~ C
6the polyoxy C of esterification is answered in the ester of aklylene glycol and chain hydrocarbon tetrabasic carboxylic acid, chain hydrocarbon tricarboxylic acids or chain hydrocarbon dicarboxylic acids
2~ C
6aklylene glycol, can list " (e
1) polyoxy C
2~ C
6aklylene glycol " the polyoxy C that illustrates in item
2~ C
6aklylene glycol.In addition, as answering the chain hydrocarbon tetrabasic carboxylic acid of esterification, chain hydrocarbon tricarboxylic acids and chain hydrocarbon dicarboxylic acids, the example illustrated in " compound (C) " item can be listed.
Above-mentioned polyoxy C
2~ C
6the ester of aklylene glycol and chain hydrocarbon tetrabasic carboxylic acid, chain hydrocarbon tricarboxylic acids or chain hydrocarbon dicarboxylic acids, except commercially available, also can by making chain hydrocarbon tetrabasic carboxylic acid, chain hydrocarbon tricarboxylic acids or chain hydrocarbon dicarboxylic acids and C under known condition
2~ C
6aklylene glycol carries out polycondensation to manufacture.
[(e
5) polyoxy C
2~ C
6the ether of aklylene glycol and chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol]
As above-mentioned polyoxy C
2~ C
6the polyoxy C of etherificate is answered in the ether of aklylene glycol and chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol
2~ C
6aklylene glycol, can list " (e
1) polyoxy C
2~ C
6aklylene glycol " the polyoxy C that illustrates in item
2~ C
6aklylene glycol.In addition, as answering the chain hydrocarbon tetrol of etherificate, chain hydrocarbon triol and chain hydrocarbon glycol, the example illustrated in " compound (A) " item can be listed, such as tetramethylolmethane, glycerol and ethylene glycol.
As above-mentioned polyoxy C
2~ C
6the commercially available product of the ether of aklylene glycol and chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol, can list such as UNILUBE (trade mark) 5TP-300KB, UNIOL (trade mark) TG-3000 and TG-4000 (Japan Oil Co's system).UNILUBE (trade mark) 5TP-300KB is the compound obtained by 1 mole of pentaerythritol and 65 moles of propylene glycol and 5 moles of ethylene glycol polycondensations, its IOB is 0.39, fusing point lower than 45 DEG C and water solubility less than 0.05g.
UNIOL (trade mark) TG-3000 is the compound obtained by 1 mole of glycerin and 50 moles of propylene glycol polycondensations, its IOB is 0.42, fusing point lower than 45 DEG C, water solubility is less than 0.05g and weight average molecular weight is about 3000.UNIOL (trade mark) TG-4000 is the compound obtained by 1 mole of glycerin and 70 moles of propylene glycol polycondensations, its IOB is 0.40, fusing point lower than 45 DEG C, water solubility is less than 0.05g and weight average molecular weight is about 4000.
Above-mentioned polyoxy C
2~ C
6the ether of aklylene glycol and chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol also can pass through under known condition chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol addition C
2~ C
6oxyalkylene manufactures.
[(F) chain hydrocarbon]
Above-mentioned chain hydrocarbon, because above-mentioned inorganic value is 0, therefore IOB is 0.00, and water solubility is roughly 0g, if therefore the chain hydrocarbon of fusing point less than about 45 DEG C then can contain in above-mentioned blood modification agent.As above-mentioned chain hydrocarbon, such as (f can be listed
1) chain alkane is as linear paraffin and branched paraffin, such as, when linear paraffin, if consider, fusing point is less than about 45 DEG C, then roughly comprise the linear paraffin that carbon number is less than 22.In addition, if consider vapour pressure, roughly comprise the linear paraffin that carbon number is more than 13.When branched paraffin, compared with linear paraffin, under same carbon number, fusing point likely reduces, and therefore can comprise the branched paraffin that carbon number is more than 22.As the commercially available product of above-mentioned hydrocarbon, such as PARLEAM 6 (Japan Oil Co) can be listed.
Above-mentioned blood modification agent detailed examination together with embodiment, finds at least to have and reduces blood viscosity and capillary effect.The menses that absorbent commodity should absorb are compared with common blood, and the protein containing intrauterine membranous wall etc., therefore they play a role to make to connect between blood cell, and blood cell easily forms string for stringing up cash in ancient times money shape (rouleau state).Therefore, the menses that absorbent commodity should absorb easily form high viscosity, top layer be non-woven fabrics or weave cotton cloth when, menses easily block between fiber, and wearer easily feels sticky feeling, and menses are in the diffusion into the surface on top layer, easily leak.
In addition, IOB be the blood modification agent of about 0.00 ~ about 0.60 because Organic is high, easily enter between blood cell, therefore think and blood cell stabilisation, blood cell can be made not easily to form string for stringing up cash in ancient times money structure.Think and make blood cell stabilisation, blood cell not easily form string for stringing up cash in ancient times money structure by above-mentioned modification agent, absorber easily absorbs menses.In absorbent commodity such as containing acrylic acid series high absorption polymer, so-called SAP, if known absorption menses, the blood cell forming string for stringing up cash in ancient times money shape covers SAP surface, SAP is difficult to play absorbent properties, but thinks that SAP easily plays absorbent properties by making blood cell stabilisation.Think in addition, with the high blood modification agent of erythrocyte affinity owing to protecting erythrocyte membrane, therefore survivable erythrocyte.
1 ~ 30g/m is preferably to the coating weight per unit area of the blood modification agent on top layer 2
2, be more preferably 3 ~ 10g/m
2.If the coating weight per unit area of blood modification agent is less than 1g/m
2then likely be difficult to blood modification agent stably to coat top layer 2, if the coating weight per unit area of blood modification agent is greater than 30g/m
2then top layer likely stick-slip.
After blood modification agent is heated to desired temperature, use the contact coating machines such as slit coating machine (slot coater), top layer 2 coated by the contact-free applicator machines such as flush coater, curtain coater, spiral coating machine.From the viewpoint of can blood modification agent dispensing area 8 equably the blood modification agent of dispersion liquid drop-wise viewpoint and damage can not be caused to top layer 2, preferably use contact-free applicator machine that blood modification agent is coated top layer 2.
When making the non-woven fabrics on top layer, blood modification agent can be coated non-woven fabrics.In addition, also in the manufacturing process of absorbent commodity 1, blood modification agent can be coated top layer 2.But, from the viewpoint of suppression equipment investment, preferably in the manufacturing process of absorbent commodity 1, blood modification agent is coated top layer 2.In addition, in order to suppress during the manufacturing process of absorbent commodity 1, the blood modification agent coating top layer 2 reduces, and preferably in close to the operation completed of absorbent commodity 1, blood modification agent is coated top layer 2.Such as before the operation being about to packaging absorbent commodity 1, blood modification agent can be coated top layer 2.
Fig. 5 is the figure for illustration of the absorbent commodity 1 of bending alar part 6 in order to pack.When packaging has absorbent commodity 1 of above technical characteristic, as shown in Figure 5 by inside the bending to width of a pair alar part 6.
Bonding part 7 is stripped sheet material 33 and covers.Thus, the bonding part 7 before the use of absorbent commodity 1 can be protected.If the sheet material that releasing sheet 33 can be peeled off for the binding agent of bonding part 7 is not particularly limited.Releasing sheet 33 such as can use releasing sheet remover being coated base material.The base material of coating remover has the thin film such as polypropylene, Low Density Polyethylene, polyvinyl alcohol, non-woven fabrics, paper etc., and remover has siloxane-based, fluorine system, isocyanates etc.
As shown in Figure 5, during packaging absorbent commodity 1, by bending, the absorbent commodity 1 of alar part 6 is configured on packaging material 31.Packaging material 31 are such as non-woven fabrics or resin film.In addition, the end of the length direction of packaging material 31 is provided with the band 32 that is adhesively fixed.Be configured at the absorbent commodity 1 on packaging material 31, together with packaging material 31 along B-B line and C-C line in length direction (Y-direction) bending.Then the band 32 that is adhesively fixed is used to maintain the bending state of absorbent commodity 1.Then, engaged by the both sides 31a of the width of the packaging material 31 of heat embossing processing by bending together with absorbent commodity 1.Thus, the package 30 shown in Fig. 6 comprising absorbent commodity 1 is made.Fig. 6 is the axonometric chart of the package 30 comprising absorbent commodity.
Fig. 7 is the schematic cross-section in the D-D line cross section representing Fig. 5.As shown in Figure 7, the sidepiece sheet 5 in the alar part 6 during bending alar part 6 contacts with the blood modification agent dispensing area 18 (with reference to Fig. 1) on top layer 2.Owing to being coated with blood modification agent at blood modification agent dispensing area 18, therefore, the top layer 2 in alar part 6 contacts with blood modification agent.But by the teat 21 on top layer 2, the sidepiece sheet 5 in alar part 6 reduces with the contact area of the blood modification agent dispensing area 18 on top layer 2.Thus, the blood modification agent of blood modification agent dispensing area 18 can be suppressed to be infiltrated up to alar part 6 and top layer 2 in alar part 6 and the engaging force between bottom 3 die down.In addition, the blood modification agent of blood modification agent dispensing area 18 can be suppressed to be transferred to the amount minimizing of the sidepiece sheet 5 of alar part 6 and the blood modification agent of blood modification agent dispensing area 18.
As mentioned above, the fibre density of the central part 23 of teat 21 is lower than the fibre density (with reference to Fig. 3) of the sidepiece 24 of teat 21 and/or recess 22.And coat the blood modification agent of the blood modification agent dispensing area 18 on top layer 2, there is the tendency that the fibre density eminence to top layer 2 is assembled.In top layer 2, the fibre density of the central part 23 of the teat 21 contacted with alar part 6 than the sidepiece of teat 21 and recess 22 low, therefore, too many blood modification agent can not be assembled at the central part 23 of teat 21.Therefore, by compared with the sidepiece 24 of teat 21 and/or the fibre density of recess 22, reduce the fibre density of the central part 23 of teat 21, the amount of the blood modification agent being transferred to alar part 6 can be reduced further.
The absorbent commodity 1 of above one embodiment of the present invention can as described belowly be out of shape.
(1) can top layer 2A as shown in Figure 8 such, form peristome 26A at the recess 22A of top layer 2A.(a) of Fig. 8 is the axonometric chart teat, recess and the peristome that are formed at top layer 2 amplified, and (b) of Fig. 8 is the top view teat, recess and the peristome that are formed at top layer 2 amplified.The fibre density of peristome 26A side is preferably higher than the fibre density of the central part 23A of teat 21A.Thus, the blood modification agent coating top layer be mostly gathered in be formed at recess 22A peristome 26A around, therefore, too many blood modification agent can not be assembled at the central part 23 of the teat 21 contacted with alar part 6.Therefore, by making the fibre density of peristome 26A side higher than the fibre density of the central part 23A of teat 21A, the amount being transferred to the blood modification agent of alar part 6 during bending alar part 6 can be reduced.Thus, the blood modification agent owing to coating top layer 2A can be suppressed to be infiltrated up to alar part 6 and the sidepiece sheet 5 forming alar part 6 is peeled off by bottom 3.
Such as shown in Figure 9, by by extending at width (CD), being arranged at netted supporting member 130 at multiple elongate components 160 that operating direction (MD) arranges, do not have breathability, peristome 26A can be formed at the recess 22A of top layer 2A.In the part not arranging elongate component 160 of netted supporting member 130, the gas 141 sprayed by blowing unit 140 by netted supporting member 130, therefore the fiber knitting sheet 120 can be pushed aside in the degree of knitting sheet 120 and formed chase 122.On the other hand, the part being provided with elongate component 160 of netted supporting member 130, the gas 141 sprayed by blowing unit 140 is not by netted supporting member 130, stopped by elongate component 160, therefore, the fiber knitting sheet 120 is can be pushed aside forcefully in the degree of knitting sheet 120 and formed peristome.Thus, peristome 26A is formed at the recess 22A of top layer 2A.By the fiber compression pushed aside in peristome 26A side, therefore the fibre density of peristome 26A side raises.
(2) can top layer 2B as shown in Figure 10 such, by the non-woven fabrics of top layer 2B will be formed with wavy bending, be formed at top layer 2B that prescribed direction extends, the teat 21B that arranges in the direction intersected with prescribed direction and recess 22B.Figure 10 is the schematic perspective view of the variation on top layer.Such as by passing through non-woven fabrics between a pair mill pinion, the top layer 2B that can make with wavy bending.In addition, also as shown in figure 11, the recess 22C formation peristome 26C of the top layer 2C of teat 21C and recess 22C can be formed with wavy bending by non-woven fabrics.
The schematic perspective view of the variation that (a) of Figure 11 is top layer, the schematic top plan view of the variation that (b) of Figure 11 is top layer.Such as there is on the surface of periphery the projection roller of multiple projections of the shapes such as needle-like, drum and cone shape, have between the backing roll (anvil roll) of the recess chimeric with projection with the surface of periphery in the position of the projection corresponding to projection roller, by with the non-woven fabrics of wavy bending, the top layer that recess 22C is formed with peristome 26C can be produced on thus.Form peristome 26C by the through non-woven fabrics of the projection of projection roller, therefore, when forming peristome 26C, pressure is applied to peristome 26C side.Therefore, the fibre density of peristome 26C side rising compared with the fibre density of the central part 23C of teat 21C.Therefore, the blood modification agent coating top layer 2C is gathered in the peristome 26C side of the recess 22C of top layer 2C, therefore can reduce the amount being transferred to the blood modification agent of alar part 6 during bending alar part 6.Thus, the blood modification agent owing to coating top layer 2C can be suppressed to be infiltrated up to alar part 6 and the sidepiece sheet 5 forming alar part 6 is peeled off by bottom 3.
(3) can as shown in figure 12, by the compression unit 8D of the inside being arrived absorber 4D by top layer 2D is formed at absorbent commodity 1D, the alar part 6 when reducing bending alar part 6 and the contact area between the blood modification agent dispensing area 18 on top layer 2.Figure 12 is the schematic cross-section of the absorbent commodity 1D of the A-A line corresponding to Fig. 1.Thus, during bending alar part 6, the amount being transferred to the blood modification agent of alar part 6 by the blood modification agent dispensing area 18 on top layer 2 can be reduced.The compression unit 8D being formed at absorbent commodity 1D can be the compression unit of wire or the compression unit of point-like.Compression unit 8D such as can be processed by embossing and be formed at absorbent commodity 1D.
Compression unit 8D is formed at thickness direction compression top layer 2D and absorber 4D, and the top layer 2D near the bottom of therefore compression unit 8D and the density of absorber 4D raise.Therefore, the blood modification agent coating top layer 2D is assembled to the bottom direction of compression unit 8D, therefore, during bending alar part 6, can reduce the amount being transferred to the blood modification agent of alar part 6 by the blood modification agent dispensing area 18 on top layer 2 further.Thus, the blood modification agent owing to coating top layer 2D can be suppressed to be infiltrated up to alar part 6 and the sidepiece sheet 5 forming alar part 6 is peeled off by bottom 3.It should be noted that, when forming compression unit 8D, if the top layer 2D filming of compression unit 8D, blood modification agent can not be infiltrated up to top layer 2D, therefore, and the non-filming of top layer 2D in preferred compressed portion 8D.
(4) if can reduce the contact area between the blood modification agent dispensing area 18 on top layer 2 and alar part 6, then the teat being formed at the blood modification agent dispensing area 18 on top layer 2 is not limited to above-mentioned teat.The teat that such as can be arranged on width (X-direction) extension at the blood modification agent dispensing area 18 on top layer 2, arrange at length direction (Y-direction).In addition, also the teat extended at length direction (Y-direction) or width (X-direction) with wavy form can be set at the blood modification agent dispensing area 18 on top layer 2.And then the teat of the shapes such as cylinder, prism, hemisphere can be set at the blood modification agent dispensing area 18 on top layer 2.
(5) in order to reduce the contact area between the blood modification agent dispensing area 18 on top layer 2 and alar part 6 further, teat can be formed at sidepiece sheet 5.Such as like that, the teat 51 extended at length direction formed with wavy bending can be arranged through at sidepiece sheet 5E by absorbent commodity 1E as shown in fig. 13 that.Figure 13 is the schematic cross-section of the absorbent commodity 1E of the A-A line corresponding to Fig. 1.The teat being formed at the blood modification agent dispensing area 18 on top layer 2 is not limited to above-mentioned teat.It should be noted that, also can be arranged on the teat of width extension at sidepiece sheet.In addition, also the teat extended at length direction or width with wavy form can be set at sidepiece sheet.And then the teat of the shapes such as cylinder, prism, hemisphere can be set at sidepiece sheet.
(6) if the compositions coating top layer is the compositions of regulation, then blood modification agent is not limited to.Such as the lotion preventing skin coarse can be coated top layer.
Embodiment
In the present invention, blood modification agent is owing to having the viscosity and capillary mechanism that reduce blood, and body fluid, by blood upgrading oxidant layer 24, can not residue in ground, top layer 2 and moves to absorber 4 and absorbed by absorber 4.Confirm blood modification agent by following embodiment and there is the viscosity and capillary mechanism that reduce blood.
[example 1]
[bleeding back the evaluation of rate and absorber transfer velocity]
[data of blood modification agent]
Prepare commercially available sanitary napkin.This sanitary napkin is formed by following: by Breathable nonwoven (composite fibre formed by polyester and polyethylene terephthalate, basic weight: 35g/m with hydrophilizing agent process
2) formed top layer, by Breathable nonwoven (composite fibre formed by polyester and polyethylene terephthalate, basic weight: 30g/m
2) formed second, comprise pulp (basic weight: 150 ~ 450g/m
2, more by central part more), acrylic acid series high absorption polymer (basic weight: 15g/m
2) and the absorber as the thin paper of core jacket, the sidepiece sheet through water repellent process and the bottom that formed by polyethylene film.
Below list the blood modification agent for testing.
[(a
1) ester of chain hydrocarbon tetrol and at least one fatty acid]
UNISTAR H-408BRS, Japan Oil Co's system
Four 2 ethyl hexanoic acid pentaerythritol esters, weight average molecular weight: about 640
UNISTAR H-2408BRS-22, Japan Oil Co's system
The mixture (58:42, weight ratio) of four 2 ethyl hexanoic acid pentaerythritol esters and two-2 ethyl hexanoic acid DOPCP, weight average molecular weight: about 520
[(a
2) ester of chain hydrocarbon triol and at least one fatty acid]
Cetiol SB45DEO, Cognis Japan system
Fatty acid is three esters of oleic acid or stearic glycerol and fatty acid
SOY42, Japan Oil Co's system
C is contained with the weight ratio of roughly 0.2:11:88:0.8
14fatty acid: C
16fatty acid: C
18fatty acid: C
20the glycerol of fatty acid (containing both satisfied fatty acid and unsaturated fatty acid) and three esters of fatty acid, weight average molecular weight: 880
Three C2L fatty acid oil glyceride, Japan Oil Co's system
C is contained with the weight ratio of roughly 37:7:56
8fatty acid: C
10fatty acid: C
12the glycerol of fatty acid and three esters of fatty acid, weight average molecular weight: about 570
Three CL fatty acid oil glyceride, Japan Oil Co's system
C is contained with the weight ratio of roughly 44:56
8fatty acid: C
12the glycerol of fatty acid and three esters of fatty acid, weight average molecular weight: about 570
PANACET 810s, Japan Oil Co's system
C is contained with the weight ratio of roughly 85:15
8fatty acid: C
10the glycerol of fatty acid and three esters of fatty acid, weight average molecular weight: about 480
PANACET 800, Japan Oil Co's system
Fatty acid is all sad (C
8) glycerol and three esters of fatty acid, weight average molecular weight: about 470
PANACET 800B, Japan Oil Co's system
Fatty acid is all 2 ethyl hexanoic acid (C
8) glycerol and three esters of fatty acid, weight average molecular weight: about 470
NA36, Japan Oil Co's system
C is contained with the weight ratio of roughly 5:92:3
16fatty acid: C
18fatty acid: C
20the glycerol of fatty acid (containing both satisfied fatty acid and unsaturated fatty acid) and three esters of fatty acid, weight average molecular weight: about 880
Three coconut oil fat acid glycerides, Japan Oil Co's system
C is contained with the weight ratio of roughly 4:8:60:25:3
8fatty acid: C
10fatty acid: C
12fatty acid: C
14fatty acid: C
16the glycerol of fatty acid (containing both satisfied fatty acid and unsaturated fatty acid) and three esters of fatty acid, weight average molecular weight: 670
Sunfat GDC-S, Japan Oil Co's system
Fatty acid is sad glycerol and the diester of fatty acid, weight average molecular weight: 340
[(a
3) ester of chain hydrocarbon glycol and at least one fatty acid]
COMPOL BL, Japan Oil Co's system
Dodecylic acid (the C of butanediol
12) monoesters, weight average molecular weight: about 270
COMPOL BS, Japan Oil Co's system
Octadecanoid acid (the C of butanediol
18) monoesters, weight average molecular weight: about 350
UNISTAR H-208BRS, Japan Oil Co's system
Two-2 ethyl hexanoic acid DOPCP, weight average molecular weight: about 360
[(c
2) there is the ester of the chain hydrocarbon tricarboxylic acids of 3 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol]
O-citroflex A-4, Tokyo HuaCheng Industry Co., Ltd's system
Weight average molecular weight: about 400
[(c
3) there is the ester of the chain hydrocarbon dicarboxylic acids of 2 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol]
Adipic acid dibutyl ester, and light pure pharmaceutical worker industry system
Weight average molecular weight: about 380
[(d
3) ester of fatty acid and aliphatic monobasic alcohol]
ELECTOL WE20, Japan Oil Co's system
Dodecylic acid (C
12) and dodecanol (C
12) ester, weight average molecular weight: about 360
ELECTOL WE40, Japan Oil Co
Tetradecanoic acid (C
14) and dodecanol (C
12) ester, weight average molecular weight: about 390
[(e
1) polyoxy C
2~ C
6aklylene glycol]
UNIOL D-1000, Japan Oil Co's system
Polypropylene glycol, weight average molecular weight: about 1000
UNIOL D-1200, Japan Oil Co's system
Polypropylene glycol, weight average molecular weight: about 1200
UNIOL D-3000, Japan Oil Co's system
Polypropylene glycol, weight average molecular weight: about 3000
UNIOL D-4000, Japan Oil Co's system
Polypropylene glycol, weight average molecular weight: about 4000
UNIOL PB500, Japan Oil Co's system
Polytetramethylene glycol, weight average molecular weight: about 500
UNIOL PB700, Japan Oil Co's system
Polyoxy butylidene polyoxypropylene glycol, weight average molecular weight: about 700
UNIOL PB1000R, Japan Oil Co's system
Polytetramethylene glycol, weight average molecular weight: about 1000
[(e
2) polyoxy C
2~ C
6the ester of aklylene glycol and at least one fatty acid]
WILBRITE cp9, Japan Oil Co's system
The OH base of two ends of polytetramethylene glycol is by hexadecanoic acid (C
16) compound of esterification, weight average molecular weight: about 1150
[(e
3) polyoxy C
2~ C
6the ether of aklylene glycol and at least one aliphatic monobasic alcohol]
UNILUBE MS-70K, Japan Oil Co's system
The stearyl ether of polypropylene glycol, about 15 repetitives, weight average molecular weight: about 1140
[(e
5) polyoxy C
2~ C
6the ether of aklylene glycol and chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol]
·UNILUBE 5TP-300KB
By the polyoxyethylene polyoxypropylene tetramethylolmethane ether generated tetramethylolmethane 1 moles of added ethylene oxide 5 moles and expoxy propane 65 moles, weight average molecular weight: 4130
UNIOL TG-3000, Japan Oil Co's system
The glyceryl ether of polypropylene glycol, about 16 repetitives, weight average molecular weight: about 3000
UNIOL TG-4000, Japan Oil Co's system
The glyceryl ether of polypropylene glycol, about 16 repetitives, weight average molecular weight: about 4000
[(f
1) chain alkane]
PARLEAM 6, Japan Oil Co's system
By the branched-chain hydrocarbons that liquid isoparaffin, isobutene. and n-butene copolymerization, then addition hydrogen are generated, the degree of polymerization: about 5 ~ about 10, weight average molecular weight: about 330
[other materials]
NA50, Japan Oil Co's system
To NA36 addition hydrogen, three esters of the glycerol that the ratio being derived from the double bond of the unsaturated fatty acid as raw material reduces and fatty acid, weight average molecular weight: about 880
(caprylic/capric) glyceryl monoacetate, Japan Oil Co's system
Sad (C is contained with the weight ratio of roughly 85:15
8) and capric acid (C
10) glycerol and the monoesters of fatty acid, weight average molecular weight: about 220
Monomuls 90-L2 lauric acid list acid esters, Cognis Japan system
Citric acid isopropyl ester, Tokyo HuaCheng Industry Co., Ltd's system
Weight average molecular weight: about 230
The different stearyl ester of malic acid two
Weight average molecular weight: about 640
UNIOL D-400, Japan Oil Co's system
Polypropylene glycol, weight average molecular weight: about 400
PEG1500, Japan Oil Co's system
Polyethylene Glycol, weight average molecular weight: about 1500 ~ about 1600
NONION S-6, Japan Oil Co's system
Polyoxyethylene monostearate, about 7 repetitives, weight average molecular weight: about 880
WILBRITE s753, Japan Oil Co's system
Polyoxyethylene polyoxypropylene polyoxy butylidene glycerol, weight average molecular weight: about 960
UNIOL TG-330, Japan Oil Co's system
The glyceryl ether of polypropylene glycol, about 6 repetitives, weight average molecular weight: about 330
UNIOL TG-1000, Japan Oil Co's system
The glyceryl ether of polypropylene glycol, about 16 repetitives, weight average molecular weight: about 1000
UNILUBE DGP-700, Japan Oil Co's system
Two glyceryl ethers of polypropylene glycol, about 9 repetitives, weight average molecular weight: about 700
UNIOX HC60, Japan Oil Co's system
Polyoxyethylene castor oil hydrogenated, weight average molecular weight: about 3570
Vaseline, Cognis Japan system
Be derived from the hydrocarbon of oil, semi-solid
The IOB of said sample, fusing point and water solubility are as described in Table 2.It should be noted that, water solubility measures according to said method, the sample add 20.0g in 100g desalted water, dissolving after 24 hours is evaluated as " 20g < ", and in 100g desalted water, but 0.05g dissolves the undissolved sample of 1.00g, is evaluated as 0.05 ~ 1.00g.In addition, for fusing point, " < 45 " refers to fusing point lower than 45 DEG C.
The skin contact face on the top layer of above-mentioned sanitary napkin is coated with above-mentioned blood modification agent.When being liquid under blood modification agent room temperature directly, and when be solid under blood modification agent room temperature, be heated to fusing point+20 DEG C, then use and control to stitch PUR HMA rifle, by each blood modification agent micronize, with roughly 5g/m
2basic weight each blood modification agent is coated whole skin contact faces on top layer.
Figure 14 is the electron micrograph that the skin contact face on the top layer in the sanitary napkin (No.2-5) of three C2L fatty acid oil glyceride is contained on top layer.As shown in Figure 14, three C2L fatty acid oil glyceride are with the microgranular surface being attached to fiber.
According to above-mentioned steps, measure and bleed back rate and absorber transfer velocity.Result as described in Table 2.
[test method]
Top layer containing each blood modification agent is placed the acrylic board (200mm × 100mm having opened hole, 125g, 40mm × 10mm hole has been opened) in central authorities, pipet is used to be dripped EDTA blood (adding ethylenediaminetetraacetic acid (hereinafter referred to as " EDTA ") to obtain to prevent from solidifying in the blood of the horse) 3g (for the first time) of the horse of 37 ± 1 DEG C by above described holes, after 1 minute, again dripped the EDTA blood 3g (for the second time) of the horse of 37 ± 1 DEG C by the hole of acrylic board with pipet.
Drip after blood in second time, remove above-mentioned acrylic board immediately, place filter paper (Advantec Toyo Kaisha, Ltd. qualitative filter paper No.2,50mm × 35mm) 10 at the position dripping blood, by it with 30g/cm
2pressure places weight.After 1 minute, take out above-mentioned filter paper, calculate " bleeding back rate " according to following formula.
Bleed back rate (%)=100 × (the filter paper quality after test-initial filter paper quality)/6
In addition, and bleed back the evaluation of rate differently, after second time drips blood, measure blood is transferred to the time of absorber " absorber transfer velocity " by top layer.Above-mentioned absorber transfer velocity refers to from dropping into top layer blood until in the surface on top layer and the inner time do not found till the redness of blood.
Bleed back the result of rate and absorber transfer velocity as shown in following table 2.
Then, the whiteness in the skin contact face on the top layer after the test of absorber transfer velocity is according to following benchmark gross evaluations.
◎: the redness of remained blood hardly, can not distinguish the position that there is blood and the position that there is not blood
Zero: the redness of remained blood a little, but be difficult to distinguish the position that there is blood and the position that there is not blood
△: the redness of remained blood a little, the known position that there is blood
×: the still redness of remained blood.
Result gathers and is shown in following table 2.
When not containing blood modification agent, the rate of bleeding back is 22.7%, and absorber transfer velocity was more than 60 seconds, for three esters of glycerol and fatty acid, the rate that bleeds back is all less than 7.0%, and absorber transfer velocity is all less than 8 seconds, and therefore known absorbent properties are greatly improved.But for the NA50 of fusing point more than 45 DEG C in three esters of glycerol and fatty acid, absorbent properties do not find large improvement.
Similarly, be for the blood modification agent of the water solubility of about 0.00 ~ about 0.05g for having the IOB of about 0.00 ~ about 0.60, the fusing point of less than about 45 DEG C and the water 100g relative to 25 DEG C, known absorbent properties are greatly improved.
Then, allow several trial volunteer wear the sanitary napkin of No.2-1 ~ No.2-47, result for the sanitary napkin containing blood modification agent of No.2-1 ~ No.2-32, even if after obtaining absorbing menses, top layer does not have sticky feeling yet, the answer that top layer is dry and comfortable.
In addition, for the sanitary napkin of No.2-1 ~ No.2-32, and particularly for No.2-1 ~ 11,15 ~ 19 and 32 containing blood modification agent sanitary napkin for, the skin contact face on the top layer after the menses that are absorbed can not be incarnadined by blood, the answer that unplessantness displeasure is few.
[example 2]
For the various blood of animal, bleed back rate according to above-mentioned steps evaluation.The blood used in experiment as described below.
[animal species]
(1) mankind
(2) horse
(3) sheep
[blood species]
Defibrinated blood: gather after blood, together with bead in conical flask stir about 5 minutes and obtaining
EDTA blood: add 12%EDTA2K normal saline 0.5mL and obtain in venous blood 65mL
[fractional distillation]
Serum or blood plasma: with the about 1900G supernatant that obtains after 10 minutes of centrifugalize defibrinated blood or EDTA blood respectively under room temperature.
Blood cell: remove serum from blood, remainder phosphate buffer normal saline (PBS) washes twice, and then adds the phosphate buffer normal saline of removed serum amount and obtains.
Except with roughly 5g/m
2basic weight be coated with outside three C2L fatty acid oil glyceride, manufacture absorbent commodity in the same manner as example 2, for above-mentioned various blood, evaluate bleed back rate.For each blood measuring 3 times, adopt its meansigma methods.
Result as described in Table 3.
Table 3
The tendency same with the EDTA blood of the horse obtained in example 2 all obtains in the blood of the mankind and sheep.In addition, same tendency is all observed at defibrinated blood and EDTA blood.
[example 3]
[evaluation of blood retentivity]
Evaluate the blood retentivity on the top layer containing blood modification agent and the top layer not containing blood modification agent.
[test method]
(1) use and control seam HMA rifle by three C2L fatty acid oil glyceride micronizes and with roughly 5g/m
2basic weight is coated by Breathable nonwoven (composite fibre formed by polyester and polyethylene terephthalate, basic weight: 35g/m
2) the skin contact face on top layer that formed.In addition, in order to compare, also prepare the top layer not having coating three C2L fatty acid oil glyceride.Then, both top layers on the top layer and uncoated three C2L fatty acid oil glyceride that are coated with three C2L fatty acid oil glyceride are cut into the size of 0.2g, correctly measure the quality (a) on cell strainer (cell strainer)+top layer.
(2) be about 2mL by the EDTA blood of side, skin contact face interpolation horse, and leave standstill 1 minute.
(3) cell strainer is installed on centrifuge tube, and carries out lower spin (spin-down) to remove the EDTA blood of unnecessary horse.
(4) weight (b) on cell strainer+the comprise top layer of the EDTA blood of horse is measured.
(5) initial absorption amount (g) on every 1g top layer is calculated according to following formula.
Initial absorption amount=[weight (b)-weight (a)]/0.2
(6) cell strainer is installed on centrifuge tube again, with about 1200G centrifugalize 1 minute under room temperature.
(7) weight (c) on cell strainer+the comprise top layer of the EDTA blood of horse is measured.
(8) absorbtivity (g) after the test on every 1g top layer is calculated according to following formula.
Absorbtivity=[weight (c)-weight (a)]/0.2 after test
(9) blood conservation rate (%) is calculated according to following formula.
Absorbtivity/initial absorption amount after blood conservation rate (%)=100 × test
It should be noted that, measure and carry out 3 times, adopt its meansigma methods.Result as described in Table 4.
Table 4
Implied the top layer containing blood modification agent, blood retentivity is low, after absorbing blood, blood promptly can be transferred to absorber.
[example 4]
[viscosity of the blood containing blood modification agent]
The viscosity of the blood containing blood modification agent uses Rheometric Expansion System ARES (Rheometric Scientific, Inc.) to measure.In the defibrinated blood of horse, add the PANACET 810s of 2 quality %, stir gently and form sample, sample is placed in the parallel-plate of diameter 50mm, makes gap be 100 μm, at 37 ± 0.5 DEG C, measure viscosity.Due to parallel-plate, uniform shear rate can not be applied to sample, but the average shearing speed of machine display is 10s
-1.
The viscosity comprising the defibrinated blood of the horse of 2 quality %PANACET 810s is 5.9mPas, and on the other hand, the viscosity of the defibrinated blood of the horse not containing blood modification agent is 50.4mPas.Therefore known, the defibrinated blood comprising the horse of 2 quality %PANACET 810s, compared with the situation not containing blood modification agent, reduces about 90% viscosity.Known blood contains the compositions such as blood cell, and has thixotropy (thixotropy), but thinks that blood modification agent of the present disclosure can reduce the viscosity of blood in low viscosity region.By reducing the viscosity of blood, absorbed menses can be made promptly to transfer to absorber by top layer.
[example 5]
[microphotograph of the blood containing blood modification agent]
The menses of healthy volunteer are collected on Saran Wrap (trade mark), add the PANACET 810s be dispersed in the phosphate buffer normal saline of 10 times of quality to its part with the PANACET 810s concentration of 1 quality %.Menses are added drop-wise to microscope slide, covered, by the erythrocytic state of observation by light microscope.Containing the microphotograph of menses of blood modification agent as shown in (a) of Figure 15, and the microphotograph of menses containing PANACET 810s is as shown in (b) of Figure 15.
As shown in Figure 15, not containing in the menses of blood modification agent, erythrocyte forms the aggregation block such as string for stringing up cash in ancient times money shape, and containing in the menses of PANACET 810s, erythrocyte stably disperses respectively.Therefore imply, blood modification agent plays the effect making erythrocyte stabilisation in blood.
[example 6]
[surface tension of the blood containing blood modification agent]
The surface tension of the blood containing blood modification agent uses consonance interface science Co., Ltd. contact angle meter Drop Master500 to measure by sessile drop method.The blood modification agent of ormal weight is being added in the defibrinated blood of sheep, and chart surface tension after fully vibrating.Measure and use machine automatically to carry out, surface tension γ is tried to achieve (with reference to Figure 16) by following formula.
γ＝g×ρ×(de)
2×1/H
G: universal gravitational constant
1/H: the correction factor of being tried to achieve by ds/de
ρ: density
De: maximum gauge
Ds: from dripping the diameter held and only improve the position of de
Density p is according to " density test method and the density/mass/volume conversion table " of JIS K 2249-1995 " 5. vibration type density test method measure at the temperature shown in following table 5.Measure the DA-505 using capital of a country electronics industry Co., Ltd..Result is as shown in table 5.
Table 5
As shown in Table 5, the blood modification agent water 100g had relative to 25 DEG C is the water solubility of about 0.00 ~ about 0.05g, and the dissolubility therefore in water is very low, can reduce the surface tension of blood.Think that the blood absorbed can not be held between the fiber on top layer, and promptly can transfer to absorber by the surface tension of reduction blood.
Can by one of embodiment and variation or multiple combination.Also can combine between variation.
More than illustrate and be only an example, invention is not by any restriction of above-mentioned embodiment.
description of reference numerals
1,1D, 1E absorbent commodity
2,2A ~ 2D top layer
3 bottoms
4,4D absorber
5,5E sidepiece sheet
6 alar parts
7 bonding parts
8 compression chases
8D compression unit
9 sealings
10 main parts
16 scavenge port contact areas
18 blood modification agent teat regions
21,21A ~ C, 51E teat
22,22A ~ 22C recess
26A, 26C peristome
120 knit sheet
121 teats
122 chases
130 netted supporting members
140 blowing units
150 suction units
160 elongate components
Claims (14)
1. an absorbent commodity, it has length direction and width, a pair alar part comprising main part and extend at width from the both side edges of this main part, described main part possess the non-woven fabrics of the liquid permeability being arranged at skin side top layer, be arranged at the liquid-impermeable bottom of the garment side of dress and be arranged at the absorber of the liquid retainability between this top layer and this bottom
At least scavenge port contact area of described top layer in the face of skin side possesses teat, and described scavenge port contact area contacts with the scavenge port of wearer,
Described top layer at least also possesses the compositions dispensing area being coated with regulation compositions at described scavenge port contact area.
2. absorbent commodity according to claim 1, wherein, described teat is included in that prescribed direction extends, the teat that arranges in the direction intersected with this prescribed direction and recess.
3. absorbent commodity according to claim 2, wherein, described teat is by knitting sheet jet gas to be formed to described top layer.
4. absorbent commodity according to claim 3, wherein, the fibre density of fibre density lower than the sidepiece of described teat of the central part of described teat and/or the fibre density of described recess.
5. absorbent commodity according to claim 2, wherein, described teat is formed by the non-woven fabrics on top layer described in bending.
6. the absorbent commodity according to any one of claim 3 ~ 5, wherein, the recess on described top layer has peristome,
The fibre density of the side of described peristome is higher than the fibre density of the central part of described teat.
7. an absorbent commodity, it has length direction and width, a pair alar part comprising main part and extend at width from the both side edges of this main part, described main part possess the non-woven fabrics of the liquid permeability being arranged at skin side top layer, be arranged at the liquid-impermeable bottom of the garment side of dress and be arranged at the absorber of the liquid retainability between this top layer and this bottom
At least scavenge port contact area in the face of skin side possess by described top layer arrive the inside of described absorber, processed by embossing and the compression unit formed, described scavenge port contact area contacts with the scavenge port of wearer,
Described top layer at least possesses the compositions dispensing area being coated with regulation compositions at described scavenge port contact area.
8. the absorbent commodity according to any one of claim 1 ~ 7, wherein, described compositions dispensing area be arranged at mode that the edge outside with the width of described a pair alar part contacts with each other by inside described a pair alar part bending to width time, in the scope of being covered by described a pair alar part.
9. the absorbent commodity according to any one of claim 1 ~ 8, wherein, described alar part has teat at the mask of skin side.
10. the absorbent commodity according to any one of claim 1 ~ 9, wherein, described compositions is have the blood modification agent that the IOB of 0.00 ~ 0.60, the fusing point of less than 45 DEG C and the water 100g relative to 25 DEG C are the water solubility of 0.00 ~ 0.05g.
11. absorbent commodities according to claim 10, wherein, described blood modification agent is selected from the group be made up of following (i) ~ (iii) and their combination in any:
(i) hydrocarbon;
(ii) have between C-C singly-bound that (ii-1) hydrocarbon part and (ii-2) be inserted into described hydrocarbon part, be selected from the group that is made up of carbonyl (-CO-) and oxygen base (-O-) one or more, the compound of identical or different group; With
(iii) there is (iii-1) hydrocarbon part, (iii-2) between the C-C singly-bound being inserted into described hydrocarbon part, be selected from the group that is made up of carbonyl (-CO-) and oxygen base (-O-) one or more, identical or different group, (iii-3) in group that replace the hydrogen atom of described hydrocarbon part, that select free carboxyl group (-COOH) and hydroxyl (-OH) to form one or more, the compound of identical or different group
At this, in the compound of (ii) or (iii), when inserting two or more oxygen base, each oxygen base does not adjoin.
12. absorbent commodities according to claim 10 or 11, wherein, described blood modification agent is selected from the group be made up of following (i ') ~ (iii ') and their combination in any:
(i ') hydrocarbon;
(ii ') have between C-C singly-bound that (ii '-1) hydrocarbon part and (ii '-2) are inserted into described hydrocarbon part, be selected from the group that is made up of carbonyl bond (-CO-), ester bond (-COO-), carbonic acid ester bond (-OCOO-) and ehter bond (-O-) one or more, the compound of identical or different key; With
(iii ') there is (iii '-1) hydrocarbon part, between the C-C singly-bound that (iii '-2) are inserted into described hydrocarbon part, be selected from the group that is made up of carbonyl bond (-CO-), ester bond (-COO-), carbonic acid ester bond (-OCOO-) and ehter bond (-O-) one or more, identical or different key, in group that (iii '-3) replace the hydrogen atom of described hydrocarbon part, that select free carboxyl group (-COOH) and hydroxyl (-OH) to form one or more, the compound of identical or different group
At this, in the compound of (ii ') or (iii '), when inserting plural identical or different key, each key does not adjoin.
13. absorbent commodities according to any one of claim 10 ~ 12, wherein, described blood modification agent is selected from the group be made up of following (A) ~ (F) and their combination in any:
(A) (A1) there is chain hydrocarbon part and replace described chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (A2) chain hydrocarbon part and replace the ester of compound of 1 carboxyl of hydrogen atom of described chain hydrocarbon part;
(B) (B1) there is chain hydrocarbon part and replace described chain hydrocarbon part hydrogen atom 2 ~ 4 hydroxyls compound, there is with (B2) chain hydrocarbon part and replace the ether of compound of 1 hydroxyl of hydrogen atom of described chain hydrocarbon part;
(C) (C1) is containing chain hydrocarbon part with replace the carboxylic acid of 2 ~ 4 carboxyls of hydrogen atom of described chain hydrocarbon part, hydroxy acid, alkoxyl acid or oxoacid, has chain hydrocarbon part and replace the ester of compound of 1 hydroxyl of hydrogen atom of described chain hydrocarbon part with (C2);
(D) compound being selected from any one key in the group be made up of ehter bond (-O-), carbonyl bond (-CO-), ester bond (-COO-) and carbonic acid ester bond (-OCOO-) between the C-C singly-bound that there is chain hydrocarbon part and be inserted into described chain hydrocarbon part;
(E) polyoxy C
2~ C
6aklylene glycol, its Arrcostab or alkyl ether; With
(F) chain hydrocarbon.
14. absorbent commodities according to any one of claim 10 ~ 13, wherein, described blood modification agent is selected from by (a
1) ester of chain hydrocarbon tetrol and at least one fatty acid, (a
2) ester of chain hydrocarbon triol and at least one fatty acid, (a
3) ester of chain hydrocarbon glycol and at least one fatty acid, (b
1) ether of chain hydrocarbon tetrol and at least one aliphatic monobasic alcohol, (b
2) ether of chain hydrocarbon triol and at least one aliphatic monobasic alcohol, (b
3) ether of chain hydrocarbon glycol and at least one aliphatic monobasic alcohol, (c
1) there is the ester of the chain hydrocarbon tetrabasic carboxylic acid of 4 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol, (c
2) there is the ester of the chain hydrocarbon tricarboxylic acids of 3 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol, (c
3) there is the ester of the chain hydrocarbon dicarboxylic acids of 2 carboxyls, hydroxy acid, alkoxyl acid or oxoacid and at least one aliphatic monobasic alcohol, (d
1) ether of aliphatic monobasic alcohol and aliphatic monobasic alcohol, (d
2) dialkyl ketone, (d
3) ester of fatty acid and aliphatic monobasic alcohol, (d
4) dialkyl carbonate, (e
1) polyoxy C
2~ C
6aklylene glycol, (e
2) polyoxy C
2~ C
6the ester of aklylene glycol and at least one fatty acid, (e
3) polyoxy C
2~ C
6the ether of aklylene glycol and at least one aliphatic monobasic alcohol, (e
4) polyoxy C
2~ C
6the ester of aklylene glycol and chain hydrocarbon tetrabasic carboxylic acid, chain hydrocarbon tricarboxylic acids or chain hydrocarbon dicarboxylic acids, (e
5) polyoxy C
2~ C
6the ether of aklylene glycol and chain hydrocarbon tetrol, chain hydrocarbon triol or chain hydrocarbon glycol, and (f
1) chain alkane, and in the group of their combination in any composition.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012082256A JP5925015B2 (en) | 2012-03-30 | 2012-03-30 | Absorbent articles |
| JP2012-082256 | 2012-03-30 | ||
| PCT/JP2013/054369 WO2013145966A1 (en) | 2012-03-30 | 2013-02-21 | Absorbent article |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104334134A true CN104334134A (en) | 2015-02-04 |
| CN104334134B CN104334134B (en) | 2016-05-11 |
Family
ID=49259246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201380028095.1A Active CN104334134B (en) | 2012-03-30 | 2013-02-21 | Absorbent commodity |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JP5925015B2 (en) |
| CN (1) | CN104334134B (en) |
| AR (1) | AR090521A1 (en) |
| TW (1) | TWI577350B (en) |
| WO (1) | WO2013145966A1 (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107708636A (en) * | 2015-06-30 | 2018-02-16 | 尤妮佳股份有限公司 | Absorbent commodity |
| CN110177531A (en) * | 2017-01-17 | 2019-08-27 | 王子控股株式会社 | Absorbent commodity |
| CN116033885A (en) * | 2020-08-25 | 2023-04-28 | 大王制纸株式会社 | Individually Wrapped Absorbent Articles |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2673772C1 (en) | 2015-07-31 | 2018-11-29 | Дзе Проктер Энд Гэмбл Компани | Forming belt conveyor for formed non-woven material |
| CN107847377A (en) | 2015-07-31 | 2018-03-27 | 宝洁公司 | Utilize the package of absorbent articles part for being molded non-woven cloth |
| US10858768B2 (en) | 2015-07-31 | 2020-12-08 | The Procter & Gamble Company | Shaped nonwoven |
| EP3239378B1 (en) | 2016-04-29 | 2019-02-13 | Reifenhäuser GmbH & Co. KG Maschinenfabrik | Device and method for the manufacture of material from continuous filaments |
| US10888471B2 (en) | 2016-12-15 | 2021-01-12 | The Procter & Gamble Company | Shaped nonwoven |
| CN110191693B (en) | 2017-01-31 | 2022-01-04 | 宝洁公司 | Shaped nonwoven fabric |
| RU2725401C1 (en) | 2017-01-31 | 2020-07-02 | Дзе Проктер Энд Гэмбл Компани | Molded non-woven material |
| DE112018000617T5 (en) | 2017-01-31 | 2019-11-07 | The Procter & Gamble Company | Molded nonwovens and articles containing them |
| EP3645775B1 (en) | 2017-06-30 | 2021-07-21 | The Procter & Gamble Company | Method for making a shaped nonwoven |
| US11214893B2 (en) | 2017-06-30 | 2022-01-04 | The Procter & Gamble Company | Shaped nonwoven |
| US11547613B2 (en) | 2017-12-05 | 2023-01-10 | The Procter & Gamble Company | Stretch laminate with beamed elastics and formed nonwoven layer |
| CA3101057A1 (en) | 2018-06-12 | 2019-12-19 | The Procter & Gamble Company | Nonwoven fabrics and absorbent articles having shaped, soft and textured nonwoven fabrics |
| JP7321191B2 (en) | 2018-06-19 | 2023-08-04 | ザ プロクター アンド ギャンブル カンパニー | Absorbent article with functionalized topsheet |
| EP3856109A1 (en) | 2018-09-27 | 2021-08-04 | The Procter & Gamble Company | Garment-like absorbent articles |
| GB2596718A (en) | 2019-03-18 | 2022-01-05 | Procter & Gamble | Shaped nonwovens that exhibit high visual resolution |
| US11999150B2 (en) | 2019-05-03 | 2024-06-04 | The Procter & Gamble Company | Nonwoven webs with one or more repeat units |
| US11819393B2 (en) | 2019-06-19 | 2023-11-21 | The Procter & Gamble Company | Absorbent article with function-formed topsheet, and method for manufacturing |
| US12053357B2 (en) | 2019-06-19 | 2024-08-06 | The Procter & Gamble Company | Absorbent article with function-formed topsheet, and method for manufacturing |
| JP7263189B2 (en) * | 2019-09-19 | 2023-04-24 | 大王製紙株式会社 | absorbent article |
| CN114746598B (en) | 2019-12-10 | 2024-01-19 | 宝洁公司 | Nonwoven web with visually distinguishable patterns and improved texture perception |
| JP7632845B2 (en) | 2021-08-31 | 2025-02-19 | 大王製紙株式会社 | Absorbent articles |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101678141A (en) * | 2007-05-15 | 2010-03-24 | 宝洁公司 | Absorbent article with coloured lotioned sheet |
| JP2011030700A (en) * | 2009-07-31 | 2011-02-17 | Daio Paper Corp | Absorptive article |
| JP2011067484A (en) * | 2009-09-28 | 2011-04-07 | Kao Corp | Absorbent article |
| JP2011080178A (en) * | 2009-10-09 | 2011-04-21 | Unicharm Corp | Nonwoven fabric |
| CN102028581A (en) * | 2009-09-30 | 2011-04-27 | 大王制纸株式会社 | Absorbent article |
| CN103841938A (en) * | 2011-09-30 | 2014-06-04 | 尤妮佳股份有限公司 | Absorbent article |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7005557B2 (en) * | 2001-07-03 | 2006-02-28 | The Procter & Gamble Company | Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| JP4451029B2 (en) * | 2001-07-25 | 2010-04-14 | ユニ・チャーム株式会社 | Disposable body fluid absorbent article |
| US20030082219A1 (en) * | 2001-10-01 | 2003-05-01 | The Procter & Gamble Company | Skin care compositions comprising low concentrations of skin treatment agents |
| JP2003192563A (en) * | 2001-12-26 | 2003-07-09 | Lion Corp | Composition for impregnating use, and impregnated material for skin protection |
| CA2570686C (en) * | 2004-06-21 | 2010-07-27 | The Procter & Gamble Company | Absorbent article with lotion-containing topsheet |
| JP4799012B2 (en) * | 2005-03-10 | 2011-10-19 | 株式会社 資生堂 | Oily solid cosmetics |
| JP2006233405A (en) * | 2005-08-16 | 2006-09-07 | Asahi Kasei Chemicals Corp | Textile treatment agent |
| JP4540590B2 (en) * | 2005-11-09 | 2010-09-08 | 花王株式会社 | Solid sheet for absorbent articles |
| JP4980685B2 (en) * | 2006-09-29 | 2012-07-18 | 大王製紙株式会社 | Absorbent articles |
| JP4812614B2 (en) * | 2006-12-27 | 2011-11-09 | 花王株式会社 | Absorbent articles |
| US20090030391A1 (en) * | 2007-07-25 | 2009-01-29 | John Lee Hammons | Absorbent article |
| JP5268416B2 (en) * | 2008-05-01 | 2013-08-21 | 大王製紙株式会社 | Method for manufacturing absorbent article |
-
2012
- 2012-03-30 JP JP2012082256A patent/JP5925015B2/en not_active Expired - Fee Related
-
2013
- 2013-02-21 CN CN201380028095.1A patent/CN104334134B/en active Active
- 2013-02-21 WO PCT/JP2013/054369 patent/WO2013145966A1/en active Application Filing
- 2013-03-27 AR ARP130101002 patent/AR090521A1/en unknown
- 2013-03-28 TW TW102111216A patent/TWI577350B/en not_active IP Right Cessation
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101678141A (en) * | 2007-05-15 | 2010-03-24 | 宝洁公司 | Absorbent article with coloured lotioned sheet |
| JP2011030700A (en) * | 2009-07-31 | 2011-02-17 | Daio Paper Corp | Absorptive article |
| JP2011067484A (en) * | 2009-09-28 | 2011-04-07 | Kao Corp | Absorbent article |
| CN102028581A (en) * | 2009-09-30 | 2011-04-27 | 大王制纸株式会社 | Absorbent article |
| JP2011080178A (en) * | 2009-10-09 | 2011-04-21 | Unicharm Corp | Nonwoven fabric |
| CN103841938A (en) * | 2011-09-30 | 2014-06-04 | 尤妮佳股份有限公司 | Absorbent article |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107708636A (en) * | 2015-06-30 | 2018-02-16 | 尤妮佳股份有限公司 | Absorbent commodity |
| CN107708636B (en) * | 2015-06-30 | 2020-08-28 | 尤妮佳股份有限公司 | Absorbent article |
| CN110177531A (en) * | 2017-01-17 | 2019-08-27 | 王子控股株式会社 | Absorbent commodity |
| CN116033885A (en) * | 2020-08-25 | 2023-04-28 | 大王制纸株式会社 | Individually Wrapped Absorbent Articles |
| CN116033885B (en) * | 2020-08-25 | 2025-04-11 | 大王制纸株式会社 | Individually wrapped absorbent articles |
Also Published As
| Publication number | Publication date |
|---|---|
| AR090521A1 (en) | 2014-11-19 |
| JP2013208384A (en) | 2013-10-10 |
| TW201402082A (en) | 2014-01-16 |
| CN104334134B (en) | 2016-05-11 |
| TWI577350B (en) | 2017-04-11 |
| JP5925015B2 (en) | 2016-05-25 |
| WO2013145966A1 (en) | 2013-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104334134A (en) | Absorbent article | |
| CN104023682B (en) | Absorbent commodity and manufacture method thereof | |
| CN104334137A (en) | Absorbent article | |
| CN104684521B (en) | Absorbent commodity | |
| CN104684516B (en) | Absorbent commodity | |
| CN104244883B (en) | Absorbent commodity | |
| CN104271090B (en) | Absorbent commodity | |
| CN104349755A (en) | Absorbent article | |
| TWI605800B (en) | Absorbent article | |
| CN104334133A (en) | Absorbent article | |
| TWI600413B (en) | Absorbent article | |
| CN104271091A (en) | Absorbent article | |
| CN104271094A (en) | Absorbent article | |
| CN104394816B9 (en) | Absorbent article | |
| CN104144664A (en) | Absorbent article | |
| CN104661629A (en) | Absorbent article | |
| CN104470481B (en) | Absorbent commodity | |
| CN104334135A (en) | Absorbent and absorbent article provided therewith | |
| CN104519844A (en) | Absorbent article | |
| TWI573574B (en) | Absorbent items | |
| CN104684518A (en) | Nonwoven and absorbent article | |
| CN104822349A (en) | Absorbent article | |
| CN104540486A (en) | Absorbent article | |
| JP6092508B2 (en) | Absorbent articles | |
| CN104271089A (en) | Absorbent article |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |